Umlobi: Janice Evans
Usuku Lokudalwa: 2 Ujulayi 2021
Ukuvuselela Usuku: 16 Unovemba 2024
Anonim
Natural Substances That Restore 6 Tissue And Function Of The Body By Diet
Ividiyo: Natural Substances That Restore 6 Tissue And Function Of The Body By Diet

-Delile

I-Grapefruit isithelo se-citrus. Abantu basebenzisa isithelo, uwoyela ophuma kucwecwe, kanye nezicucu ezivela embewini njengomuthi. Ukukhishwa kwembewu yamagilebhisi kucutshungulwa kusuka kumbewu yamagilebhisi kanye nomgogodla otholwe njengomkhiqizo ovela ekukhiqizeni ijusi lamagilebhisi. I-glycerin yemifino ingezwa kumkhiqizo wokugcina ukunciphisa i-asidi nobumuncu.

I-Grapefruit ivame ukuthathwa ngomlomo ukuze yehlise isisindo. Ibuye isetshenziselwe i-asthma, i-cholesterol ephezulu, umdlavuza, nezinye izimo eziningi, kepha abukho ubufakazi obuhle besayensi bokuxhasa lokhu okunye ukusetshenziswa.

Ekudleni naseziphuzweni, i-grapefruit idliwa njengesithelo, ijusi, futhi isetshenziswa njengengxenye yokunambitha.

Ekukhiqizeni, uwoyela wamagilebhisi nokhishwa kwembewu kusetshenziswa njengengxenye yephunga ezinsizeni nakwezimonyo; futhi njengomhlanzi wezindlu wezithelo, imifino, inyama, indawo yekhishi, izitsha, nokunye.

Kwezolimo, ukukhishwa kwembewu yamagilebhisi kusetshenziselwa ukubulala amabhaktheriya nefungus, ukulwa nokukhula kwesikhunta, ukubulala ama-parasites ekudleni kwezilwane, ukugcina ukudla kanye nokubulala amagciwane ngamanzi.

Kubalulekile ukukhumbula ukuthi ukuxhumana kwezidakamizwa nejusi lamagilebhisi kubhalwe kahle. I-chemistry ye-grapefruit iyahluka ngohlobo, izimo ezikhulayo, kanye nenqubo esetshenzisiwe ukukhipha ujusi. Ngaphambi kokungeza i-grapefruit ekudleni kwakho noma kuhlu lwakho lwemithi yemvelo, hlola umhlinzeki wakho wezokunakekelwa kwezempilo uma uthatha imishanguzo.

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze ISITHELO SEGILEBHISI zimi kanje:


Kungenzeka kusebenze ...

  • Ukukhuluphala ngokweqile. Ukuthatha umkhiqizo othize oqukethe i-orange enoshukela, i-orange orange, kanye nezithelo zomvini kubukeka kwehlisa isisindo somzimba namafutha omzimba kubantu abakhuluphele ngokweqile. Olunye ucwaningo lukhombisa nokuthi ukudla isithelo samagilebhisi esisha nsuku zonke kwandisa ukwehla kwesisindo kubantu abakhuluphele ngokweqile.

Ubufakazi obanele bokukala ukusebenza kwe ...

  • Isifuba Somoya. Olunye ucwaningo lukhombisa ukuthi ukudla izithelo ezisawolintshi ezicebile ngovithamini C, kufaka phakathi ubhamubhamu nezinye, kungathuthukisa ukusebenza kwamaphaphu kubantu abane-asthma. Kepha ezinye izifundo azikhombisanga le nzuzo.
  • I-eczema (i-atopic dermatitis). Ucwaningo lokuqala lukhombisa ukuthi ukukhishwa kwembewu yamagilebhisi kunganciphisa ukuqunjelwa, igesi, nokungakhululeki esiswini kubantu abane-eczema. Le nzuzo ingahle ibangelwe umthelela wamagilebhisi kumagciwane wamathumbu.
  • I-cholesterol ephezulu. Ucwaningo lokuqala lubonisa ukuthi ukuthatha i-grapefruit pectin nsuku zonke amasonto ayi-16 kunciphisa inani eliphelele le-cholesterol kanye ne-cholesterol ephansi ye-lipoprotein (LDL noma "embi") kuya ku-high-density lipoprotein (HDL noma "okuhle") cholesterol uma kuqhathaniswa nesisekelo sokuqala.
  • Amazinga aphezulu amafutha abizwa nge-triglycerides egazini (hypertriglyceridemia). Ukudla i-grapefruit eyodwa ngosuku kubonakala ukunciphisa inani eliphelele le-cholesterol, i-low-density lipoprotein (LDL noma i- "bad") cholesterol, kanye namazinga e-triglyceride kubantu abanamazinga aphezulu e-triglyceride.
  • Izintwala. Ucwaningo lwakuqala lukhombisa ukuthi ukufaka isinqandawo esiqukethe i-grapefruit ekhishwa ezinweleni zezingane imizuzu eyi-10-20 kubulala izintwala. Ukufaka isicelo se-shampoo futhi ezinsukwini eziyi-10 kamuva kusiza ukususa noma iziphi izinti ezisele.
  • Izinduna.
  • Ukucindezeleka.
  • Izikhalazo zokugaya ukudla kubantu abane-eczema.
  • Ukuqina kwemithambo yegazi (i-atherosclerosis).
  • Ubuhlungu bekhanda.
  • Izifo.
  • Ukukhathala kwemisipha.
  • Ukuvimbela umdlavuza.
  • Ukukhuthaza ukukhula kwezinwele.
  • I-Psoriasis.
  • Ukucindezeleka.
  • Toning isikhumba.
  • Ukutheleleka kwemvubelo yesitho sangasese sowesifazane.
  • Ezinye izimo.
Ubufakazi obengeziwe buyadingeka ukukala ukusebenza kukapapende walokhu kusetshenziswa.

I-Grapefruit ingumthombo wevithamini C, i-fiber, i-potassium, i-pectin, nezinye izakhamzimba. Ezinye izingxenye zingaba nemiphumela yokulwa ne-antioxidant engasiza ukuvikela amaseli ekulimaleni noma ekunciphiseni i-cholesterol.

Akucaci ukuthi uwoyela ungasebenza kanjani ekusetshenzisweni kokwelashwa.

Lapho ithathwa ngomlomo: Amagilebhisi ngu CISHE UVIKILE kumanani asetshenziswa ngokujwayelekile njengokudla kanye OKUNGENZEKA UKUPHEPHA lapho iphuzwa ngomlomo njengomuthi. Kepha isithelo samagilebhisi sinjalo MHLAWUMBI ANGIPHEPHILE lapho ithathwa ngomlomo ngamanani amakhulu.

Uma uthatha noma yimiphi imithi, hlola umhlinzeki wakho wezokunakekelwa kwempilo ngaphambi kokungeza ubhamubhamu ekudleni kwakho noma ukuwusebenzise njengomuthi. I-Grapefruit ihlangana nohlu olude lwemithi (bheka ukuthi "Ingabe kukhona ukuxhumana nemithi?" Ngezansi).

Ukuqapha okukhethekile nezixwayiso:

Ukukhulelwa nokuncelisa ibele: Akwanele okwaziwayo ngokusetshenziswa kwamagilebhisi ngesikhathi sokukhulelwa nokuncelisa. Hlala ohlangothini oluphephile futhi ugweme ukusetshenziswa.

Umdlavuza webele: Kukhona ukukhathazeka ngokuphepha kokuphuza ngokweqile ijusi lamagilebhisi. Olunye ucwaningo luphakamisa ukuthi abesifazane abangemva kokuya esikhathini abasebenzisa ilitha noma ngaphezulu ijusi lamagilebhisi nsuku zonke banamathuba angama-25% kuya kwangama-30% wokuthola umdlavuza webele. Ijusi lamagilebhisi liyancipha ukuthi i-estrogen idilike kanjani emzimbeni futhi ingakhuphula amazinga e-estrogen emzimbeni. Ucwaningo oluningi luyadingeka ukuqinisekisa lokhu okutholakele. Kuze kube yilapho kwaziwa okuningi, gwema ukuphuza kakhulu ijusi lamagilebhisi, ikakhulukazi uma unomdlavuza webele noma usengozini enkulu kunokujwayelekile yokuba nomdlavuza webele.

Izifo zemisipha yenhliziyo: Ukudla ijusi lamagilebhisi kungakhuphula amandla esigqi senhliziyo esingajwayelekile. Abantu abanalezi zifo kufanele badle ijusi lamagilebhisi ngokulinganisela.

Umdlavuza nezimo ezibucayi zehormone: Ukudla inani elikhulu lamagilebhisi kungakhuphula amazinga ama-hormone ngakho-ke kwandisa ubungozi bezimo ezibucayi zehomoni. Abesifazane abanezimo ezizwela i-hormone kufanele bagweme i-grapefruit.

Ukushaya kwenhliziyo okungajwayelekile: Ukudla inani elikhulu lamagilebhisi noma ujusi wamagilebhisi kungahle kube kubi ukushaya kwenhliziyo okungajwayelekile. Ungasebenzisi i-grapefruit uma unalesi simo.

Okukhulu
Ungathathi le nhlanganisela.
I-Amiodarone (Cordarone)
Ijusi lamagilebhisi lingakhuphula inani lomzimba elithathe i-amiodarone (Cordarone). Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-amiodarone (Cordarone) kungakhuphula imiphumela emibi kanye nemiphumela emibi. Gwema ukuphuza ujusi wamagilebhisi uma uthatha i-amiodarone (Cordarone).
U-Artemether (Artenam, Paluther)
Umzimba uphula i-artemether (Artenam, Paluther) ukuze uyiqede. Ijusi lamagilebhisi linganciphisa ukuthi umzimba weqa kanjani i-artemether (i-Artenam, Paluther). Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-artemether (Artenam, Paluther) kungakhuphula imiphumela kanye nemiphumela emibi ye-artemether (Artenam, Paluther). Ungaphuzi ijusi yamagilebhisi uma uthatha i-artemether (Artenam, Paluther).
I-Atorvastatin (Lipitor)
I-Atorvastatin (Lipitor) uhlobo lomuthi wokwehlisa i-cholesterol owaziwa nge- "statin." Umzimba wephula i-atorvastatin (Lipitor) ukuze uyiqede. Ijusi lamagilebhisi linganciphisa ukuthi umzimba wephuka kanjani ngokushesha i-atorvastatin (Lipitor). Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-atorvastatin (Lipitor) kungakhuphula imiphumela kanye nemiphumela emibi yalo muthi.
I-Buspirone (BuSpar)
Ijusi lamagilebhisi lingakhuphula ubungako bomzimba we-buspirone (BuSpar). Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-buspirone (BuSpar) kungakhuphula imiphumela kanye nemiphumela emibi ye-buspirone (BuSpar).
I-Carbamazepine (Tegretol)
Ijusi lamagilebhisi lingakhuphula inani lomzimba elithatha i-carbamazepine (Tegretol). Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-carbamazepine (Tegretol) kungakhuphula imiphumela kanye nemiphumela emibi ye-carbamazepine (Tegretol).
I-Carvedilol (Coreg)
Umzimba wephula i-carvedilol (Coreg) ukuze uyiqede. Ijusi lamagilebhisi libukeka lincipha ukuthi umzimba wephula kanjani i-carvedilol (Coreg) ngokushesha okukhulu. Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-carvedilol (Coreg) kungakhuphula imiphumela kanye nemiphumela emibi ye-carvedilol (Coreg).
I-Celiprolol (Celicard)
I-Grapefruit ibonakala inciphisa ukuthi ingakanani i-celiprolol (Celicard) efakwa. Lokhu kunganciphisa ukusebenza kwe-celiprolol (Celicard). Ukwehlukaniswa kokuphathwa kwe-celiprolol (Celicard) nokusetshenziswa kwe-grapefruit okungenani amahora ama-4.
I-Cisapride (Propulsid)
Ijusi lamagilebhisi lingancipha ukuthi umzimba ususa kanjani ngokushesha i-cisapride (Propulsid). Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-cisapride (Propulsid) kungakhuphula imiphumela kanye nemiphumela emibi ye-cisapride (Propulsid).
I-Clomipramine (Anafranil)
Umzimba wephula i-clomipramine (Anafranil) ukuze uyiqede. Ijusi lamagilebhisi lingancipha ukuthi umzimba ususa kanjani ngokushesha i-clomipramine (Anafranil). Ukuthatha ijusi lamagilebhisi kanye ne-clomipramine (Anafranil) kungakhuphula imiphumela kanye nemiphumela emibi ye-clomipramine (Anafranil).
IClopidogrel (i-Plavix)
I-Clopidogrel (i-Plavix) iyidrug. Ama-Prodrugs adinga ukwenziwa ukuthi asebenze ngumzimba ukuze asebenze. I-Grapefruit ibonakala inciphisa ukuthi ingakanani i-clopidogrel (Plavix) eyenziwe yasebenza ngumzimba. Lokhu kungaholela ekusebenzeni okunciphile kwe-clopidogrel. Ungathathi i-grapefruit nge-clopidogrel.
ICyclosporine (Neoral, Sandimmune)
I-Grapefruit ingakhuphula ukuthi ingakanani i-cyclosporine (Neoral, Sandimmune) ebanjwa ngumzimba. Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-cyclosporine (Neoral, Sandimmune) kungakhuphula imiphumela emibi ye-cyclosporine.
I-Dextromethorphan (i-Robitussin DM, nabanye)
Umzimba wephula i-dextromethorphan (i-Robitussin DM, abanye) ukuze uyiqede. Amagilebhisi angahle anciphise ukuthi umzimba wephula kanjani ngokushesha i-dextromethorphan (i-Robitussin DM, abanye). Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-dextromethorphan (iRobitussin DM, abanye) kungakhuphula imiphumela kanye nemiphumela emibi ye-dextromethorphan (Robitussin DM, abanye).
Ama-Estrogens
Umzimba wephula ama-estrogens ukuze uwaqede. Ijusi lamagilebhisi libukeka lincipha ukuthi umzimba wephula kanjani ama-estrogen ngokushesha futhi ukhuphule nokuthi umzimba umunca malini i-estrogen. Ukuphuza ijusi lamagilebhisi ngenkathi uthatha ama-estrogens kungakhuphula amazinga e-estrogen nemiphumela emibi ehlotshaniswa ne-estrogen njengomdlavuza webele.

Amanye amaphilisi e-estrogen afaka phakathi ama-equine estrogens ahlanganisiwe (Premarin), ethinyl estradiol, estradiol (Climara, Vivelle, Estring), namanye.
I-Etoposide (VePesid)
I-Grapefruit inganciphisa ukuthi ingakanani i-etoposide (VePesid) umzimba oyithathayo. Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-etoposide (VePesid) kunganciphisa ukusebenza kwe-etoposide (VePesid). Ukugwema lokhu kuhlangana, hlukanisa ukuthatha lo muthi ekudleni izithelo zomvini okungenani amahora ama-4.
IHalofantrine
Umzimba wephula i-halofantrine ukuze uyiqede. Ijusi lamagilebhisi kubonakala lincipha ukuthi umzimba wephula kanjani i-halofantrine ngokushesha. Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-halofantrine kungakhuphula amazinga e-halofantrine nemiphumela emibi ehlotshaniswa ne-halofantrine, kufaka phakathi ukushaya kwenhliziyo okungavamile.
I-Lovastatin (Mevacor)
ILovastatin (Mevacor) uhlobo lomuthi wokwehlisa i-cholesterol owaziwa nge- "statin." Umzimba wephula i-lovastatin (Mevacor) ukuze uyiqede. Ijusi lamagilebhisi lingancipha ukuthi umzimba wephula kanjani i-lovastatin (Mevacor) ngokushesha okukhulu. Ukuphuza ijusi lamagilebhisi ngenkathi uthatha i-lovastatin (Mevacor) kungakhuphula imiphumela kanye nemiphumela emibi yalo muthi.

Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 3A4 (CYP3A4))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. Ijusi lamagilebhisi lingahle linciphise ukuthi isibindi sehla kanjani ngokushesha eminye imithi. Ukuphuza ujusi wamagilebhisi ngenkathi uthatha eminye imithi eyehliswe yisibindi kungakhuphula imiphumela kanye nemiphumela emibi yeminye imithi. Ngaphambi kokuthatha izithelo zomvini, khuluma nomhlinzeki wakho wezokunakekelwa kwempilo uma uthatha noma yimiphi imishanguzo eguqulwa yisibindi.

Eminye imishanguzo eshintshwe yisibindi ifaka i-lovastatin (Mevacor), ketoconazole (Nizoral), itraconazole (Sporanox), fexofenadine (Allegra), triazolam (Halcion), neminye eminingi.
Imithi yokwenyuka komfutho wegazi (iCalcium channel blockers)
Ijusi lamagilebhisi lingakhuphula imishanguzo engakanani yomfutho wegazi ophakeme omunca umzimba. Ukuphuza ijusi lamagilebhisi ngenkathi uthatha imithi ethile yengcindezi ephezulu yegazi kungadala ukuthi umfutho wegazi lakho wehle kakhulu.

Eminye imishanguzo yomfutho wegazi ophakeme ifaka phakathi i-nifedipine (Adalat, Procardia), verapamil (Calan, Isoptin, Verelan), diltiazem (Cardizem), isradipine (DynaCirc), felodipine (Plendil), amlodipine (Norvasc), neminye.
Imithi ihanjiswe ngamaphampu kumaseli (Organic anion-transporting polypeptide substrates)
Eminye imithi ihanjiswa ngamaphampu kumaseli. I-Grapefruit ingashintsha ukuthi la mapampu asebenza kanjani futhi yehlise ukuthi eminye imithi ingena kanjani emzimbeni. Lokhu kungenza le mithi ingasebenzi kahle. Ukugwema lokhu kuhlangana, hlukanisa ukuthatha le mithi ekudleni izithelo zomvini okungenani amahora amane.

Eminye yale mithi ehanjiswa amaphampu kumaseli ifaka i-bosentan (Tracleer), i-celiprolol (i-Celicard, enye), i-etoposide (i-VePesid), i-fexofenadine (i-Allegra), i-fluoroquinolone antibiotic, i-glyburide (i-Micronase, i-Diabeta), i-irinotecan (i-Camptosar), i-methotrexate , paclitaxel (Taxol), saquinavir (Fortovase, Invirase), rifampin, statins, talinolol, torsemide (Demadex), troglitazone, kanye ne-valsartan (Diovan).
Imithi engadala ukushaya kwenhliziyo okungajwayelekile (izidakamizwa ezandisa izikhawu ze-QT)
I-Grapefruit ingathinta isigqi senhliziyo yakho. Ukuthatha i-grapefruit kanye nemithi engadala ukushaya kwenhliziyo okungajwayelekile kungadala imiphumela emibi kakhulu, kufaka phakathi ukushaya kwenhliziyo okungajwayelekile.
Eminye imithi engadala ukushaya kwenhliziyo okungajwayelekile ifaka i-amiodarone (Cordarone), i-disopyramide (i-Norpace), i-dofetilide (iTikosyn), i-ibutilide (i-Corvert), i-procainamide (i-Pronestyl), i-quinidine, i-sotalol (i-Betapace), i-thioridazine (i-Mellaril), neminye eminingi.
Imithi esetshenziselwa ukwehlisa i-cholesterol (ama-Statins)
Umzimba wephula imithi ethile yokwehlisa i-cholesterol ebizwa nge- "statins" ukuze uyiqede. Ijusi lamagilebhisi linganciphisa ukuthi umzimba wephuka kanjani ngokushesha "ama-statins". Ukuphuza ujusi wamagilebhisi ngenkathi uthatha "ama-statins" athile kungakhuphula imiphumela kanye nemiphumela emibi yale mithi.
I-Grapefruit ibonakala incipha ukuthi umzimba weqa kanjani ngokushesha "ama-statins" athile afaka i-lovastatin (Mevacor), i-simvastatin (i-Zocor), ne-atorvastatin (i-Lipitor).
I-Methadone (Dolophine)
Umzimba wephula i-methadone (Dolophine) ukuze uyiqede. Ijusi lamagilebhisi linganciphisa ukuthi umzimba wephula kanjani i-methadone (i-Dolophine) ngokushesha okukhulu. Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-methadone (i-Dolophine) kungakhuphula imiphumela kanye nemiphumela emibi ye-methadone (Dolophine).
I-Methylprednisolone
Umzimba wephula i-methylprednisolone ukuze uyiqede. Ijusi lamagilebhisi linganciphisa ukuthi umzimba ususa kanjani ngokushesha i-methylprednisolone. Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-methylprednisolone kungakhuphula imiphumela kanye nemiphumela emibi ye-methylprednisolone.
I-Praziquantel (Biltricide)
Umzimba wephula i-praziquantel (i-Biltricide) ukuze uyiqede. Ijusi lamagilebhisi linganciphisa ukuthi umzimba wephula kanjani ngokushesha ipraziquantel (iBiltricide). Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-praziquantel (i-Biltricide) kungakhuphula imiphumela kanye nemiphumela emibi ye-praziquantel (Biltricide).
I-Quinidine
Umzimba wephula i-quinidine ukuze uyiqede. Ijusi lamagilebhisi linganciphisa ukuthi umzimba ususa kanjani i-quinidine ngokushesha okukhulu. Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-quinidine kungakhuphula amathuba okuba nemiphumela engemihle.
IScopolamine (iTransderm Scop)
Umzimba wephula i-scopolamine ukuze uyiqede. Ijusi lamagilebhisi linganciphisa ukuthi umzimba wephula kanjani ngokushesha i-scopolamine. Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-scopolamine kungakhuphula imiphumela kanye nemiphumela emibi ye-scopolamine.
Imithi yokwelapha (i-Benzodiazepines)
Imithi yokwelapha ingabangela ukulala nokuzela. Ijusi lamagilebhisi linganciphisa ukuthi umzimba wephula ngokushesha kanjani eminye imishanguzo yokuthambisa. Ukuphuza ujusi wamagilebhisi ngenkathi uthatha imishanguzo ethambisa umzimba kungakhuphula imiphumela kanye nemiphumela engemihle yemithi ethile yokuthambisa.

Eminye imishanguzo yokuthambisa (i-benzodiazepines) engahle ihlangane nejusi lamagilebhisi ihlanganisa i-diazepam (i-Valium), i-midazolam (i-Versed), i-quazepam (i-Doral), ne-triazolam (i-Halcion).
I-Sildenafil (Viagra)
Umzimba wephula i-sildenafil (Viagra) ukuze uyiqede. I-Grapefruit inganciphisa ukuthi umzimba wephula kanjani i-sildenafil (Viagra) ngokushesha okukhulu. Ukuphuza ijusi lamagilebhisi ngenkathi uthatha i-sildenafil (Viagra) kungakhuphula imiphumela kanye nemiphumela emibi ye-sildenafil (Viagra).
I-Simvastatin (Zocor)
Umzimba wephula i-simvastatin (iZocor) ukuze uyiqede. Ijusi lamagilebhisi lingahle linciphise ukuthi umzimba wephula ngokushesha kangakanani i-simvastatin (iZocor). Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-simvastatin (Zocor) kungakhuphula imiphumela kanye nemiphumela emibi yalo muthi.

I-Tacrolimus (Prograf)
Umzimba wephula i-tacrolimus (Prograf) ukuze uyiqede. Amagilebhisi anganciphisa ukuthi umzimba wephula kanjani i-tacrolimus (Prograf) ngokushesha okukhulu.Ukudla i-grapefruit noma ukuphuza ijusi lamagilebhisi ngenkathi uthatha i-tacrolimus (Prograf) kungakhuphula imiphumela kanye nemiphumela emibi ye-tacrolimus (Prograf). Gwema ukudla isithelo samagilebhisi noma ukuphuza ijusi lamagilebhisi uma uthatha i-tacrolimus.
I-Terfenadine (Seldane)
I-Grapefruit ingakhuphula ukuthi ingakanani i-terfenadine (Seldane) etholwa ngumzimba. Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-terfenadine (Seldane) kungakhuphula imiphumela kanye nemiphumela emibi ye-terfenadine (Seldane).
I-Ticagrelor (Brilinta)
Umzimba wephula i-ticagrelor (Brilinta) ukuze uyiqede. I-Grapefruit inganciphisa ukuthi umzimba wephula kanjani i-ticagrelor (Brilinta) ngokushesha okukhulu. Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-ticagrelor (i-Brilinta) kungakhuphula imiphumela kanye nemiphumela emibi ye-ticagrelor (Brilinta).
Maphakathi
Qaphela ngale nhlanganisela.
I-Aliskiren (Tekturna, Rasilez)
I-Aliskiren (Tekturna, Rasilez) ihanjiswa ngamaphampu kumaseli emzimbeni. I-Grapefruit ingashintsha ukuthi la mapampu asebenza kanjani futhi yehlise ukuthi ingakanani i-aliskiren (Tekturna, Rasilez) engena emzimbeni. Lokhu kungenza lo muthi ungasebenzi kahle. Ukugwema lokhu kuhlangana, hlukanisa ukuthatha lo muthi ekudleni izithelo zomvini okungenani amahora ama-4.
I-Blonanserin (Lonasen)
Umzimba wephula i-blonanserin (Lonasen) ukuze uyiqede. I-Grapefruit ingakhuphula i-blonanserin (Lonasen) engakanani umzimba omunca futhi wehlise ukuthi umzimba ususa kanjani i-blonanserin (Lonasen) ngokushesha okukhulu. Ukuphuza izithelo zomvini ngenkathi uthatha i-blonanserin (Lonasen) kungakhuphula imiphumela emibi ye-blonanserin (Lonasen).
I-Budesonide (Entocort, UCERIS)
Umzimba wephula i-budesonide (Pulmicort) ukuze uyiqede. I-Grapefruit ingakhohlisa ukuthi umzimba ususa kanjani ngokushesha i-budesonide (Pulmicort). Ukuphuza i-grapefruit ngenkathi uthatha i-budesonide (Pulmicort) kungakhuphula imiphumela emibi ye-budesonide (Pulmicort).
Ikhafeyini
Umzimba wephula i-caffeine ukuze uyiqede. I-Grapefruit ingahle ikhohlise ukuthi umzimba ususa kanjani ngokushesha i-caffeine. Ukuphuza i-grapefruit ngenkathi uthatha i-caffeine kungakhuphula imiphumela emibi ye-caffeine kufaka phakathi i-jitteriness, ikhanda elibuhlungu, nokushaya kwenhliziyo okusheshayo.
I-Colchicine
Umzimba wephula i-colchicine ukuze uyiqede. I-Grapefruit inganciphisa ukuthi umzimba ususa kanjani i-colchicine ngokushesha okukhulu. Kepha olunye ucwaningo lukhombisa ukuthi i-grapefruit ayinciphisi ukuthi umzimba ususa i-colchicine ngokushesha kangakanani. Kuze kube kwaziwa okuningi, landela noma imiphi imiyalelo kwilebuli ye-colchicine ehlobene nokutholwa kukapapayi.
I-Dapoxetine (Priligy)
Umzimba wephula i-dapoxetine (Priligy) ukuze uyiqede. Ijusi lamagilebhisi lingancipha ukuthi umzimba ususa kanjani ngokushesha i-dapoxetine (Priligy). Ukuthatha ijusi lamagilebhisi kanye ne-dapoxetine (Priligy) kungakhuphula imiphumela kanye nemiphumela emibi ye-dapoxetine.
I-Erythromycin
Umzimba wephula i-erythromycin ukuze uyiqede. I-Grapefruit inganciphisa ukuthi umzimba ususa kanjani i-erythromycin ngokushesha. Ukuthatha ijusi lamagilebhisi kanye ne-erythromycin kungakhuphula imiphumela kanye nemiphumela emibi ye-erythromycin.
I-Fexofenadine (Allegra)
I-Grapefruit inganciphisa ukuthi ingakanani i-fexofenadine (Allegra) etholwa ngumzimba. Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-fexofenadine (Allegra) kunganciphisa ukusebenza kwe-fexofenadine (Allegra). Ukugwema lokhu kuhlangana, hlukanisa ukuthatha lo muthi ekudleni izithelo zomvini okungenani amahora ama-4.
I-Fluvoxamine (Luvox)
Ijusi lamagilebhisi lingakhuphula ukuthi umzimba umunca malini i-fluvoxamine (Luvox). Ukuphuza ijusi lamagilebhisi ngenkathi uthatha i-fluvoxamine (Luvox) kungakhuphula imiphumela kanye nemiphumela emibi ye-fluvoxamine (Luvox).
I-Itraconazole (Sporanox)
I-Itraconazole (Sporanox) isetshenziselwa ukwelapha ukutheleleka kwefungal. Ijusi lamagilebhisi lingathinta ukuthi i-itraconazole (Sporanox) engakanani umzimba oyithathayo. Kepha akukho lwazi olwanele lokwazi ukuthi ngabe lokhu kuxhumana kuyinkinga enkulu.
I-Levothyroxine (Synthroid, abanye)
I-Levothyroxine (Synthroid, abanye) ihanjiswa ngamaphampu kumaseli emzimbeni. I-Grapefruit ingashintsha ukuthi la mapampu asebenza kanjani futhi yehlise ukuthi ingakanani i-levothyroxine (Synthroid, abanye) engena emzimbeni. Lokhu kungenza lo muthi ungasebenzi kahle. Ukugwema lokhu kuhlangana, hlukanisa ukuthatha lo muthi ekudleni izithelo zomvini okungenani amahora ama-4.
I-Losartan (Cozaar)
Isibindi senza i-losartan (Cozaar) isebenze. Ijusi lamagilebhisi lingahle linciphise ukuthi umzimba uyisebenzisa kanjani ngokushesha i-losartan (Cozaar). Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-losartan (Cozaar) kunganciphisa ukusebenza kwe-losartan.
Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 1A2 (CYP1A2))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. Ijusi lamagilebhisi lingahle linciphise ukuthi isibindi sehla kanjani ngokushesha eminye imithi. Ukuthatha ijusi lamagilebhisi kanye neminye imishanguzo eyehliswe yisibindi kungakhuphula imiphumela kanye nemiphumela emibi yeminye imithi. Ngaphambi kokuthatha ijusi lamagilebhisi khuluma nomhlinzeki wakho wezokunakekelwa kwempilo uma uthatha noma yimiphi imithi eshintshwa yisibindi.

Eminye imithi eshintshwa yisibindi ifaka i-amitriptyline (Elavil), i-haloperidol (i-Haldol), i-ondansetron (i-Zofran), i-propranolol (i-Inderal), i-theophylline (i-Theo-Dur, abanye), i-verapamil (i-Calan, i-Isoptin, abanye), neminye.
Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 2C19 (CYP2C19))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. Ijusi lamagilebhisi lingahle linciphise ukuthi isibindi sehla kanjani ngokushesha eminye imithi. Ukuthatha ijusi lamagilebhisi kanye neminye imishanguzo eyehliswe yisibindi kungakhuphula imiphumela kanye nemiphumela emibi yeminye imithi. Ngaphambi kokuthatha ijusi lamagilebhisi khuluma nomhlinzeki wakho wezokunakekelwa kwempilo uma uthatha noma yimiphi imithi eshintshwa yisibindi.

Eminye imishanguzo eguqulwa isibindi ifaka i-omeprazole (Prilosec), i-lansoprazole (i-Prevacid), ne-pantoprazole (i-Protonix); diazepam (Valium); i-carisoprodol (iSoma); i-nelfinavir (i-Viracept); nabanye.
Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 2C9 (CYP2C9))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. Ijusi lamagilebhisi lingahle linciphise ukuthi isibindi sehla kanjani ngokushesha eminye imithi. Ukuthatha ijusi lamagilebhisi kanye neminye imishanguzo eyehliswe yisibindi kungakhuphula imiphumela kanye nemiphumela emibi yeminye imithi. Ngaphambi kokuthatha ijusi lamagilebhisi khuluma nomhlinzeki wakho wezokunakekelwa kwempilo uma uthatha noma yimiphi imithi eshintshwa yisibindi.

Eminye imishanguzo eguqulwa isibindi ifaka phakathi i-diclofenac (Cataflam, Voltaren), ibuprofen (Motrin), meloxicam (Mobic), ne-piroxicam (Feldene); i-celecoxib (Celebrex); i-amitriptyline (u-Elavil); i-warfarin (i-Coumadin); i-glipizide (iGlucotrol); losartan (Cozaar); nabanye.
I-Nadolol (Corgard)
INadolol (Corgard) ihanjiswa ngamaphampu kumaseli emzimbeni. I-Grapefruit ingashintsha ukuthi la mapampu asebenza kanjani futhi yehlise ukuthi ingakanani i-nadolol (Corgard) engena emzimbeni. Lokhu kungenza lo muthi ungasebenzi kahle. Kodwa-ke, olunye ucwaningo lukhombisa ukuthi i-grapefruit ayithinti ukuthi ingakanani i-nadolol (Corgard) engena emzimbeni. Kuze kube kwaziwa okuningi, landela noma imiphi imiyalo kwilebula le-nadolol (Corgard) elihlobene nokudla izithelo zomvini.
I-Nilotinib (Tasigna)
Ijusi lamagilebhisi lingakhuphula ukuthi umzimba umunca kangakanani i-Nilotinib (Tasigna). Ukuphuza ujusi wamagilebhisi ngenkathi uthatha iNilotinib (Tasigna) kungakhuphula imiphumela emibi kanye nemiphumela engemihle. Gwema ukuphuza ujusi wamagilebhisi uma uthatha iNilotinib (Tasigna).
I-Oxycodone (Oxycontin)
Umzimba wephula i-oxycodone (Oxycontin) ukuze uyiqede. Ijusi lamagilebhisi linganciphisa ukuthi umzimba wephula kanjani i-oxycodone (Oxycontin) ngokushesha okukhulu. Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-oxycodone (Oxycontin) kungakhuphula imiphumela kanye nemiphumela emibi ye-Oxycodone (Oxycontin).
I-Pitavastatin (Livalo)
Umzimba wephula i-pitavastatin (Livalo) ukuze uyiqede. Ijusi lamagilebhisi linganciphisa ukuthi umzimba wephula kanjani i-pitavastatin (Livalo) ngokushesha okukhulu. Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-pitavastatin (Livalo) kungakhuphula imiphumela kanye nemiphumela emibi yalo muthi.

Okuphambili
Ijusi lamagilebhisi lingakhuphula inani le-primaquine etholakala emzimbeni. Akucaci ukuthi lokhu kungaba namiphi imiphumela. Qaphela ngale nhlanganisela.
I-Saquinavir (Fortovase, Invirase)
Ukuphuza ujusi wamagilebhisi kungakhuphula ukuthi ingakanani i-saquinavir (i-Fortovase, i-Invirase) ewuthatha umzimba. Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-saquinavir (i-Fortovase, i-Invirase) kungakhuphula imiphumela kanye nemiphumela emibi ye-saquinavir.
I-Sertraline (Zoloft)
Umzimba wephula i-sertraline ukuze uyiqede. Amagilebhisi anganciphisa ukuthi umzimba wephula kanjani i-sertraline ngokushesha okukhulu. Ukuphuza ijusi lamagilebhisi ngenkathi uthatha i-sertraline kungakhuphula imiphumela kanye nemiphumela emibi ye-sertraline.
I-Sunitinib (Sutent)
Umzimba wephula i-sunitinib (Sutent) ukuze uyiqede. Ijusi lamagilebhisi linganciphisa ukuthi umzimba wephula kanjani i-sunitinib (Sutent) ngokushesha okukhulu. Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-sunitinib (Sutent) kungakhuphula imiphumela kanye nemiphumela emibi ye-sunitinib (Sutent). Kepha olunye ucwaningo lukhombisa ukuthi umthelela wamagilebhisi ku-sunitinib (Sutent) akuyona inkinga enkulu. Kuze kube kwaziwa okuningi, landela noma imiphi imiyalo kulebula le-sunitinib (Sutent) ehlobene nokudla izithelo zomvini.
I-Talinolol
Ijusi lamagilebhisi linganciphisa ukuthi ingakanani i-talinolol etholakala emzimbeni. Ukuphuza ijusi lamagilebhisi nge-talinolol kunganciphisa imiphumela ye-talinolol.
Theophylline
Ukuphuza ijusi lamagilebhisi kunganciphisa imiphumela ye-theophylline. Akukho lwazi olwanele lokwazi ukuthi ngabe lokhu kuyinkinga enkulu yini.
I-Tolvaptan (Samsca)
Umzimba wephula i-tolvaptan (Samsca) ukuze uyiqede. Amagilebhisi anganciphisa ukuthi umzimba wephula kanjani ngokushesha i-tolvaptan (Samsca). Ukuphuza ujusi wamagilebhisi ngenkathi uthatha i-tolvaptan (Samsca) kungakhuphula imiphumela kanye nemiphumela emibi ye-tolvaptan (Samsca).
I-Warfarin (Coumadin)
I-Warfarin (i-Coumadin) isetshenziselwa ukunciphisa ukubamba kwegazi. Ukuphuza ijusi lamagilebhisi kungakhuphula imiphumela ye-warfarin (i-Coumadin) futhi kwandise amathuba okulimala nokopha. Qiniseka ukuthi uhlolwa igazi lakho njalo. Umthamo we-warfarin yakho (i-Coumadin) ungadinga ukuguqulwa.
Okuncane
Qaphela ngale nhlanganisela.
I-Acebutolol (Sectral)
I-Acebutolol (Sectral) ihanjiswa ngamaphampu kumaseli emzimbeni. I-Grapefruit ingashintsha ukuthi la mapampu asebenza kanjani futhi yehlise ukuthi ingakanani i-acebutolol (Sectral) engena emzimbeni. Lokhu kungenza lo muthi ungasebenzi kahle. Ukugwema lokhu kuhlangana, hlukanisa ukuthatha lo muthi ekudleni izithelo zomvini okungenani amahora ama-4.
I-Amprenavir (Agenerase)
I-Grapefruit ingahle yehle kancane ukuthi ingakanani i-amprenavir (Agenerase) efakwa ngumzimba. Kepha lokhu kuxhumana kungenzeka akuyona inkinga enkulu.
Ilayisensi
Ukuphuza ujusi wamagilebhisi lapho uthatha i-licorice kungakhuphula ikhono le-licorice lokubangela ukuncipha kwe-potassium.
Imvubelo ebomvu
I-Grapefruit (ijusi noma isithelo) ishintsha indlela umzimba osebenzisa ngayo imvubelo ebomvu. Amagilebhisi angakhuphula inani le-lovastatin kusuka kwimvubelo ebomvu egazini.
Unkulunkulu wokuduma umvini
Umvini unkulunkulu wokuduma uqukethe i-triptolide. Umzimba wephula i-triptolide ukuze uyiqede. I-Grapefruit inganciphisa ukuthi umzimba wephula kanjani i-triptolide ngokushesha. Ukuphuza ujusi wezithelo zomvini ngenkathi uthatha ukuduma kukankulunkulu womvini oqukethe i-triptolide kungakhuphula imiphumela kanye nemiphumela emibi yokuduma kukankulunkulu womvini.
Amanzi amathoni
I-Grapefruit ingaphazamisa indlela umzimba ocubungula ngayo i-quinine equkethwe emanzini we-tonic. Abantu abanenkinga yesigqi senhliziyo (i-QT syndrome ende, ngokwesibonelo) kufanele bagweme ukuthatha izithelo zamagilebhisi namanzi we-tonic ndawonye, ​​ngoba leyo nhlanganisela ingase isibhebhethekise isimo senhliziyo yabo.
Iwayini
Ijusi lamagilebhisi lingahle linciphise ukuthi isibindi sehla kanjani ngokushesha eminye imithi. Lokhu kungakhuphula imiphumela emibi yale mithi. Ukungeza iwayini elibomvu ekuxubeni kungakhuphula le miphumela emibi kakhulu. Iwayini elimhlophe, nokho, akubonakali lisebenzisana nesithelo samagilebhisi noma imithi edilizwa yisibindi.
Imithamo elandelayo ifundwe ocwaningweni lwesayensi:

NGOMLOMO:
  • OkokukhuluphalaKusetshenziswe ama-450-700 mg womkhiqizo othize oqukethe i-orange enoshukela, i-orange orange, kanye ne-grapefruit kabili ngosuku nsuku zonke amasonto ayi-12. Ukudla uhhafu wamagilebhisi kathathu nsuku zonke, ukuphuza ama-ounces ayisishiyagalombili wejusi lamagilebhisi kathathu nsuku zonke, noma ukuthatha amaphilisi aqukethe isithelo samagilebhisi esomisiwe sonke esingu-500 mg kathathu ngaphambi kokudla amasonto ayi-12 nakho kusetshenzisiwe.
I-Bioflavonoid Complex, i-Bioflavonoid Concentrate, i-Bioflavonoid Extract, i-Bioflavonoids, i-Bioflavonoïdes, i-Bioflavonoïdes d'grume, i-Citrus Bioflavones, i-Citrus Bioflavonoid, i-Citrus Bioflavonoid Extract, i-Citrus Bioflavonoids, i-Citrus Flavones, i-Citrus Flavadisidi yeCitrus, i-Citrus Flavadon, Cindezela u-Grapefruit Oil, Complexe Bioflavono Compde, Complexe Bioflavonoïde de Pamplemousse, Concentré de Bioflavonoïde, CSE, Expressed Grapefruit Oil, Extrait de Bioflavonoïde, Extrait de Bioflavonoïdes d'Agrumes, Extrait de Graines de Prague de Prague, Isithabathaba Esiwumbukwane, 'Agrumes, Grapefruit Bioflavonoid Complex, Grapefruit Extract, Grapefruit Oil, Grapefruit Seed Extract, Grapefruit Seed Glycerate, GSE, Huile de Pamplemousse, Huile de Pamplemousse Pressée à Froid, Pamplemousse, Pamplemousse Rose, Paradisapfel, Grapefapfel, Grapefapfel, Pinkape Amafutha eShaddock, Isitshalo Esimisiwe Samagilebhisi, eToronja.

Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.


  1. U-Ershad M, Cruz MD, Mostafa A, Mckeever R, Vearrier D, Greenberg MI. I-opioid toxidrome elandela ukusetshenziswa kwejusi lamagilebhisi lapho kulungiswa i-methadone. J Addict Med 2019; [I-Epub ngaphambi kokuphrinta]. Buka okungaqondakali.
  2. UChorin E, uHochstadt A, uGranot Y, et al. Ijusi lamagilebhisi landisa isikhathi se-QT samavolontiya anempilo neziguli ezine-QT syndrome ende. Isigqi senhliziyo. I-pii: S1547-527130368-6. Buka okungaqondakali.
  3. UShang DW, uWang ZZ, uHu HT, et al. Imiphumela yokudla nejusi lamagilebhisi ku-pharmacokinetics yedosi elilodwa le-blonanserin ezifundweni ezinempilo zaseChina. I-Eur J Clin Pharmacol. 2018; 74: 61-67. Buka okungaqondakali.
  4. ISantes-Palacios R, uRomo-Mancillas A, uCamacho-Carranza R, u-Espinosa-Aguirre JJ. Ukuvinjelwa kwe-enzyme yomuntu neyamagundane ye-CYP1A1 ngama-juice we-grapefruit compounds. I-Toxicol Lett. 2016 Septhemba 6; 258: 268-75. Buka okungaqondakali.
  5. UKawaguchi-Suzuki M, uNasiri-Kenari N, uShuster J, et al. Imiphumela ye-low-furanocoumarin hybrid grapefruit juice ukusetshenziswa kwe-midazolam pharmacokinetics. UJ Clin Pharmacol. 2017 Mar; 57: 305-11. Buka okungaqondakali.
  6. UMelough MM, uVance TM, uLee SG, et al. I-Furocoumarin kinetics ku-plasma nomchamo wabantu abadala abaphilile kulandela ukusetshenziswa kwamagilebhisi (i-citrus paradise Macf.) Nejusi lezithelo zomvini. J Agric Ukudla Chem. 2017 Mar 29 [Epub ngaphambi kokuphrinta] Buka okungaqondakali.
  7. UJia Y, Liu J, Xu J. Ithonya lejusi lamagilebhisi ku-pharmacokinetics ye-triptolide kumagundane wejusi lamagilebhisi ngemiphumela ye-triptolide. I-Xenobiotica. 2017 Ephreli 16: 1-5. Buka okungaqondakali.
  8. I-Abdlekawy KS, i-Donia AM, i-Elbarbry F. Imiphumela yesithelo samagilebhisi nama-pomegranate kuma-pharmacokinetic izakhiwo ze-dapoxetine ne-midazolam ezifundweni ezinempilo. I-Eur J Drug Metab Pharmacokinet. 2017 Juni; 42: 397-405. Buka okungaqondakali.
  9. UTsuji H, Ohmura K, Nakashima R, et al. Ukusebenza nokuphepha kokudla kwejusi yamagilebhisi okuhambisana nokwelashwa kwe-tacrolimus kwiziguli ezixhumene nezifo zezifo. I-Intern Med. 2016; 55: 1547-52. Buka okungaqondakali.
  10. I-Hung WL, i-Suh JH, i-Wang Y. I-Chemistry nemiphumela yezempilo yama-furanocoumarins ku-grapefruit. J Ukudla izidakamizwa. 2017 uJan; 25: 71-83. Buka okungaqondakali.
  11. UMouly S, uLloret-Linares C, uSellire PO, uSene D, uBergmann JF. Ngabe ukusebenzelana komtholampilo kokusebenzisana kwezidakamizwa nezidakamizwa nezidakamizwa kukhawulelwe kujusi wamagilebhisi kanye ne-Saint-John's Wort? IPharmacol Res. 2017 Ephreli; 118: 82-92. Buka okungaqondakali.
  12. UBailey DG. Ukubikezela ukubaluleka komtholampilo kokusebenzisana kwamagilebhisi-izithelo: inqubo eyinkimbinkimbi. UJ Clin Pharm Ther. 2017 Ephreli; 42: 125-27. Buka okungaqondakali.
  13. UDallas C, uGerbi A, u-Elbez Y, uCaillard P, uZamaria N, uCloarec M. Ucwaningo lomtholampilo ukuhlola ukusebenza nokuphepha kokukhishwa kwe-citrus polyphenolic kwe-red orange, grapefruit, ne-orange (iSinetrol-XPur) ekuphathweni kwesisindo kanye nemingcele ye-metabolic kubantu abakhuluphele ngokweqile. I-Phytother Res. 2014 Feb; 28: 212-8. Buka okungaqondakali.
  14. UDallas C, uGerbi A, uTenca G, uJuchaux F, uBernard FX. Umphumela we-Lipolytic we-polyphenolic citrus owomile okhishwe i-orange ebomvu, i-grapefruit, i-orange (i-SINETROL) kuma-adipocyte womzimba womuntu. Indlela yokusebenza ngokuvimbela i-cAMP-phosphodiesterase (PDE). I-Phytomedicine. 2008 Okthoba; 15: 783-92. Buka okungaqondakali.
  15. UDahan A, u-Amidon GL. Ijusi lamagilebhisi nezakhi zalo zikhulisa ukumunzwa kwamathumbu we-colchicine: ukuxhumana okungenzeka kube yingozi kanye nendima ye-p-glycoprotein. I-Pharm Res. 2009 Ephreli; 26: 883-92. Buka okungaqondakali.
  16. UGoldbart A, uCindezela J, uSofer S, uKapelushnik J. Eduzane nokudakwa okuyingozi kwe-colchicine enganeni. Umbiko wecala. U-Eur J Udokotela wezingane. 2000; 159: 895-7. Buka okungaqondakali.
  17. UPeterson JJ, Beecher GR, Bhagwat SA, et al. I-Flavanones ku-grapefruit, ulamula, nama-limes: Ukuhlanganiswa nokubuyekezwa kwedatha evela ezincwadini zokuhlaziya. J Ukudla Comp Comp. 2006; 19: S74-S80.
  18. I-Xiao YJ, Hu M, Tomlinson B. Imiphumela yejusi lamagilebhisi ku-cortisol metabolism ezifundweni zesilisa ezinempilo zaseShayina. Ukudla Chem Toxicol. 2014 Dis; 74: 85-90. Buka okungaqondakali.
  19. van Erp NP, Baker SD, Zandvliet AS, Ploeger BA, den Hollander M, Chen Z, den Hartigh J, König-Quartel JM, Guchelaar HJ, Gelderblom H. Ukwanda okuncane kokuvezwa yi-sunitinib ngejusi lamagilebhisi. Umdlavuza Chemother Pharmacol. 2011 Mar; 67: 695-703. Buka okungaqondakali.
  20. I-Tapaninen T, Neuvonen PJ, i-Niemi M. Ijusi lamagilebhisi lehlisa kakhulu ukugxila kwe-plasma kwe-OATP2B1 ne-CYP3A4 substrate aliskiren. Umtholampilo Pharmacol Ther. 2010 Septhemba; 88: 339-42. Buka okungaqondakali.
  21. UTanaka S, Uchida S, Miyakawa S, Inui N, Takeuchi K, Watanabe H, Namiki N. Ukuqhathaniswa kwesikhathi esivimbayo sejusi lamagilebhisi ku-organic anion-transporting polypeptide kanye ne-cytochrome P450 3A4. IBiol Pharm Bull. 2013; 36: 1936-41. Buka okungaqondakali.
  22. IShoaf SE, iMallikaarjun S, iBricmont P. Umphumela wejusi lamagilebhisi ku-pharmacokinetics ye-tolvaptan, umphikisi we-non-peptide arginine vasopressin, ezifundweni ezinempilo. I-Eur J Clin Pharmacol. 2012 Feb; 68: 207-11. Buka okungaqondakali.
  23. I-Seidegård J, i-Randvall G, i-Nyberg L, i-Borgå O.Ukuxhumana kwejusi lamagilebhisi ne-oral budesonide: umphumela olinganayo ekwakhiweni okusheshayo nokukhululwa kokubambezeleka. I-Pharmazie. 2009 Julayi; 64: 461-5. Buka okungaqondakali.
  24. I-Piccirillo G, Magrì D, Matera S, Magnanti M, Pasquazzi E, Schifano E, Velitti S, Mitra M, Marigliano V, Paroli M, Ghiselli A. Imiphumela yejusi lamagilebhisi elibomvana ngokuhlukahluka kwe-QT ezigulini ezine-cardiomyopathy ehlanganisiwe izifundo ezinempilo. Humusha i-Res. 2008 Meyi; 151: 267-72. Buka okungaqondakali.
  25. Nieminen TH, Hagelberg NM, Saari TI, Neuvonen M, Neuvonen PJ, Laine K, Olkkola KT. Ijusi lamagilebhisi lithuthukisa ukuvezwa kwe-oxycodone yomlomo. I-Basic Clin Pharmacol Toxicol. 2010 Okthoba; 107: 782-8. Buka okungaqondakali.
  26. IMisaka S, Miyazaki N, Yatabe MS, Ono T, Shikama Y, Fukushima T, Kimura J. Pharmacokinetic kanye ne-pharmacodynamic ukusebenzisana kwe-nadolol ne-itraconazole, i-rifampicin nejusi lamagilebhisi kuzitolontiya ezinempilo. UJ Clin Pharmacol. 2013 Julayi; 53: 738-45. Buka okungaqondakali.
  27. Ieiri I, Doi Y, Maeda K, Sasaki T, Kimura M, Hirota T, Chiyoda T, Miyagawa M, Irie S, Iwasaki K, Sugiyama Y. Microdosing clinical clinic: pharmacokinetic, pharmacogenomic (SLCO2B1), nokusebenzisana (ijusi lamagilebhisi) amaphrofayli e-celiprolol alandela i-microdose yomlomo kanye nomthamo wokwelashwa. UJ Clin Pharmacol. 2012 Julayi; 52: 1078-89. Buka okungaqondakali.
  28. Hu M, Mak VW, Yin OQ, Chu TT, Tomlinson B. Imiphumela yejusi lamagilebhisi kanye ne-SLCO1B1 388A> G polymorphism ku-pharmacokinetics ye-pitavastatin. Izidakamizwa Metab Pharmacokinet. 2013; 28: 104-8. Buka okungaqondakali.
  29. IHolmberg MT, iTornio A, i-Neuvonen M, i-Neuvonen PJ, i-Backman JT, i-Niemi M. Ijusi lamagilebhisi livimbela ukwenziwa komzimba kwe-clopidogrel. Umtholampilo Pharmacol Ther. 2014 uMar; 95: 307-13. Buka okungaqondakali.
  30. IHolmberg MT, iTornio A, iJoutsi-Korhonen L, i-Neuvonen M, i-Neuvonen PJ, i-Lassila R, i-Niemi M, i-Backman JT. Ijusi lamagilebhisi lenyusa ngokuphawulekayo ukugxila kwe-plasma nemiphumela ye-antiplatelet ye-ticagrelor ezifundweni ezinempilo. UBr J Clin Pharmacol. 2013 Juni; 75: 1488-96. Buka okungaqondakali.
  31. U-Abdel-Ghaffar F, Semmler M, Al-Rasheid K, Klimpel S, Mehlhorn H. Ukusebenza kwesithelo samagilebhisi ezintweni zasekhanda: isilingo somtholampilo. I-Parasitol Res. 2010 Jan; 106: 445-9. Buka okungaqondakali.
  32. U-Ionescu G, uKiehl R, uWichmann-Kunz F, no-al. Ukukhishwa kwembewu ye-citrus yomlomo ku-atopic eczema: ku-in vitro nasezifundweni ze-vivo ku-microflora yamathumbu. UJ Orthomol Med 1990; 5: 155-157.
  33. Ameer, B., Weintraub, R. A., Johnson, J. V., Yost, R. A., noRouseff, R. L. Flavanone ukumuncwa ngemuva kokuphathwa kwe-naringin, hesperidin, kanye ne-citrus. I-Clin Pharmacol Ther 1996; 60: 34-40. Buka okungaqondakali.
  34. I-Pisarik, P. Ingcindezi yokwehlisa ingcindezi yegazi yokwengeza ijusi lamagilebhisi ku-nifedipine ne-terazosin esigulini esine-hypertension enamandla kakhulu. I-Arch Fam. Med 1996; 5: 413-416. Buka okungaqondakali.
  35. UCurhan, G. C., Willett, W. C., Rimm, E. B., Spiegelman, D., noStampfer, M. J. Ucwaningo olulindelekile lokusetshenziswa kweziphuzo kanye nobungozi bamatshe ezinso. Ngingu-J Epidemiol. 2-1-1996; 143: 240-247. Buka okungaqondakali.
  36. UCerda, J. J., Normann, S. J., Sullivan, M. P., Burgin, C. W., Robbins, F. L., Vathada, S., noLeelachaikul, P. Ukuvinjelwa kwe-atherosclerosis yi-pectin yokudla ku-microswine ene-hypercholesterolemia eqhubekayo. Ukusakazwa 1994; 89: 1247-1253. Buka okungaqondakali.
  37. UBaekey, P.A., Cerda, J. J., Burgin, C. W., Robbins, F. L., Rice, R. W., noBaumgartner, T. G. Grapefruit pectin inhibits hypercholesterolemia and atherosclerosis ezingulubeni ezincane. Umtholampilo Cardiol 1988; 11: 597-600. Buka okungaqondakali.
  38. UMcLundie, A. C. Ukulahleka kwamazinyo okwenziwe endaweni yangakini kanye nokwelashwa kwayo ngama-laminates e-porcelain. Ukubuyisela. 1991; 7: 43-44. Buka okungaqondakali.
  39. UGoo, LQ, Chen, QY, Wang, X., Liu, YX, Chu, XM, Cao, XM, Li, JH, no Yamazoe, Y. Izindima ezahlukahlukene ze-pummelo furanocoumarin ne-cytochrome P450 3A5 * 3 polymorphism ekugcineni nesenzo se-felodipine. I-Curr Drug Metab 2007; 8: 623-630. Buka okungaqondakali.
  40. UFerdman, R. M., Ong, P. Y., neSonto, uJ. A. Pectin anaphylaxis nokuhlangana okungenzeka kube khona ukungezwani komzimba ne-cashew. U-Ann Isifo Sokulwa Nezifo Somoya I-Immunol 2006; 97: 759-760. Buka okungaqondakali.
  41. UFujioka, K., Greenway, F., Sheard, J., no-Ying, Y. Imiphumela yesithelo samagilebhisi esisindweni nasekumelaneni ne-insulin: ubudlelwane ne-metabolic syndrome. J Med Ukudla 2006; 9: 49-54. Buka okungaqondakali.
  42. UGorinstein, S., Caspi, A., Libman, I., Lerner, HT, Huang, D., Leontowicz, H., Leontowicz, M., Tashma, Z., Katrich, E., Feng, S., no I-Trakhtenberg, S. I-grapefruit ebomvu inomthelela omuhle ezingeni le-serum triglyceride ezigulini ezinesifo sokuqina kwemithambo yegazi: izifundo ze-vitro kanye nabantu. J Agric Ukudla Chem 3-8-2006; 54: 1887-1892. Buka okungaqondakali.
  43. UKumar, A., Teuber, S. S., Naguwa, S., Prindiville, T., noGershwin, M. E. Eosinophilic gastroenteritis kanye ne-urticaria eyenziwe nge-citrus. Umtholampilo Wezinkinga Zokungezwani komzimba Immunol 2006; 30: 61-70. Buka okungaqondakali.
  44. U-Armanini, D., uCalo, L., noSemplicini, A. Pseudohyperaldosteronism: izindlela ze-pathogenetic. ICrit Rev Clin Lab Sci 2003; 40: 295-335. Buka okungaqondakali.
  45. Palermo, M., Armanini, D., noDelitala, G. Ijusi yamagilebhisi ivimbela i-11beta-hydroxysteroid dehydrogenase ku-vivo, kumuntu. I-Clin Endocrinol. (Oxf) 2003; 59: 143-144. Buka okungaqondakali.
  46. UWangensteen, H., Molden, E., Christensen, H., noMaltud, K. E. Ukukhonjwa kwe-epoxybergamottin njenge-CYP3A4 inhibitor esikhungweni sezithelo zomvini. I-Eur J Clin Pharmacol 2003; 58: 663-668. Buka okungaqondakali.
  47. UTrinchieri, A., Lizzano, R., Bernardini, P., Nicola, M., Pozzoni, F., Romano, AL, Serrago, MP, noConalanieri, S. Umphumela womthwalo omkhulu wejusi lamagilebhisi ekukhipheni i-citrate kwe-urinary nezici zokubeka umchamo ekwakhiweni kwamatshe ezinso. I-Dig Dig 2002; 34 Isilinganiso 2: S160-S163. Buka okungaqondakali.
  48. USardi, A., Geda, C., Nerici, L., noBertello, P. [Rhabdomyolysis kanye nomfutho wegazi ophakeme obangelwa ukubonakala ngokweqile kwama-mineralocorticoids: umbiko wecala]. U-Ann Ital Med Int 2002; 17: 126-129. Buka okungaqondakali.
  49. UBailey, D. G., Dresser, G. K., Kreeft, J. H., Munoz, C., Freeman, D. J., noBend, J. R. Grapefruit-felodipine ukuxhumana: umphumela wezithelo ezingalungisiwe kanye nezithako ezisebenzayo ezinokwenzeka. IClin Pharmacol Ther 2000; 68: 468-477. Buka okungaqondakali.
  50. UWason, S., DiGiacinto, J. L., noDavis, M. W. Imiphumela yesithelo samagilebhisi kanye namajusi e-orange aseSeville kuzakhiwo ze-pharmacokinetic ze-colchicine ezifundweni ezinempilo. Umtholampilo Ther 2012; 34: 2161-2173. Buka okungaqondakali.
  51. UKiani, J. no-Imam, S. Z. Ukubaluleka kokwelashwa kwejusi lamagilebhisi kanye nokuhlangana kwayo nezidakamizwa ezahlukahlukene. Umsoco. J. 2007; 6:33. Buka okungaqondakali.
  52. U-Odou, P., Ferrari, N., Barthelemy, C., Brique, S., Lhermitte, M., Vincent, A., Libersa, C., noRobert, H. Grapefruit ukusebenzisana kwejusi-nifedipine: ukubandakanyeka okungenzeka kokuningi izindlela. UJ Clin Pharm Ther 2005; 30: 153-158. Buka okungaqondakali.
  53. Desta, Z., Kivisto, K. T., Lilja, J. J., Backman, J. T., Soukhova, N., Neuvonen, P. J., noFlorckhart, D. A. Stereoselective pharmacokinetics ye-cisapride kumavolontiya anempilo kanye nomphumela wokuphathwa okuphindaphindiwe kwejusi lamagilebhisi. UBr J Clin Pharmacol 2001; 52: 399-407. Buka okungaqondakali.
  54. UKivisto, K. T., Lilja, J. J., Backman, J. T., noNeuvonen, P. J. Ukusetshenziswa okuphindaphindiwe kwejusi lamagilebhisi kukhulisa kakhulu ukugxila kwe-plasma ye-cisapride. IClin Pharmacol Ther 1999; 66: 448-453. Buka okungaqondakali.
  55. ULilja, J. J., Laitinen, K., noNeuvonen, P. J. Imiphumela yejusi lamagilebhisi ekumungeni kwe-levothyroxine. UBr J Clin Pharmacol 2005; 60: 337-341. Buka okungaqondakali.
  56. UGlaeser, H., Bailey, DG, Dresser, GK, Gregor, JC, Schwarz, UI, McGrath, JS, Jolicoeur, E., Lee, W., Leake, BF, Tirona, RG, noKim, RB Isishushumbisi sezidakamizwa zamathumbu expression kanye nomthelela wejusi lamagilebhisi kubantu. I-Clin Pharmacol Ther 2007; 81: 362-370. Buka okungaqondakali.
  57. USigusch, H., Henschel, L., Kraul, H., Merkel, U., noHoffmann, A. Ukungabi nomphumela wejusi lamagilebhisi ku-diltiazem ukutholakala kwezihloko ezijwayelekile. I-Pharmazie 1994; 49: 675-679. Buka okungaqondakali.
  58. I-Paine, i-MF, i-Widmer, i-WW, i-Hart, i-HL, i-Pusek, i-SN, i-Beavers, i-KL, i-Criss, i-AB, i-Brown, i-SS, i-Thomas, i-BF ne-Watkins, i-PB Ijusi lamagilebhisi elingenawo u-furanocoumarin lisungula ama-furanocoumarins njengabalamuli besithelo samagilebhisi ukuxhumana kwejusi-felodipine. Ngingu-J J Nutriti 2006; 83: 1097-1105. Buka okungaqondakali.
  59. Yee, G. C., Stanley, D. L., Pessa, L. J., Dalla, Costa T., Beltz, S. E., Ruiz, J., noLowenthal, D. T. Umphumela wejusi lezithelo zomvini ku-cyclosporin yegazi. ILancet 4-15-1995; 345: 955-956. Buka okungaqondakali.
  60. Schwarz, U. I., Johnston, P. E., Bailey, D. G., Kim, R. B., Mayo, G., noMilstone, A. Umthelela weziphuzo ezithambile ezisawolintshi ezihlobene nejusi lamagilebhisi ku-ciclosporin. UBr J Clin Pharmacol 2006; 62: 485-491. Buka okungaqondakali.
  61. U-Lee, M., Min, D. I., Ku, Y. M., noFlanigan, M. Umphumela wejusi lamagilebhisi ku-pharmacokinetics ye-microemulsion cyclosporine ezifundweni zase-Afrika zaseMelika uma kuqhathaniswa nezifundo zaseCaucasus: ingabe umehluko wobuhlanga ubalulekile? UJ Clin Pharmacol 2001; 41: 317-323. Buka okungaqondakali.
  62. Ku, Y. M., Min, D. I., noFlanigan, M. Umphumela wejusi lamagilebhisi ku-pharmacokinetics ye-microemulsion cyclosporine kanye ne-metabolite yayo kumavolontiya anempilo: ingabe umehluko wokwakheka kubalulekile? UJ Clin Pharmacol 1998; 38: 959-965. Buka okungaqondakali.
  63. UDucharme, M. P., Warbasse, L.H, no-Edwards, D. J. Ukuchithwa kwe-cyclosporine efakwa ngaphakathi nangomlomo ngemuva kokuphathwa ngejusi lamagilebhisi. I-Clin Pharmacol Ther 1995; 57: 485-491. Buka okungaqondakali.
  64. Bistrup, C., Nielsen, F. T., Jeppesen, U. E., noDieperink, H. Umphumela wejusi lamagilebhisi ku-Sandimmun Neoral ukumuncwa phakathi kwabamukeli be-renal allograft. Ukushayelwa kukaNephrol. 2001; 16: 373-377. Buka okungaqondakali.
  65. Uno, T., Ohkubo, T., Motomura, S., noSugawara, K. Umphumela wejusi lamagilebhisi ekubunjweni kwama-enantiomers e-manidipine ezifundweni ezinempilo. UBr J Clin Pharmacol 2006; 61: 533-537. Buka okungaqondakali.
  66. URashid, J., McKinstry, C., Renwick, A. G., Dirnhuber, M., Waller, D. G., noGeorge, C. F. Quercetin, i-in vitro inhibitor ye-CYP3A, ayinikeli ekuxhumaneni phakathi kwe-nifedipine nejusi lamagilebhisi. UBr J Clin Pharmacol 1993; 36: 460-463. Buka okungaqondakali.
  67. Soons, PA, Vogels, BA, Roosemalen, MC, Schoemaker, HC, Uchida, E., Edgar, B., Lundahl, J., Cohen, AF, noBreimer, DD Ijusi lamagilebhisi kanye ne-cimetidine inhibit metabolism e-stereoselective ye-nitrendipine ebantwini . I-Clin Pharmacol Ther 1991; 50: 394-403. Buka okungaqondakali.
  68. URashid, T. J., Martin, U., Clarke, H., Waller, D. G., Renwick, A. G., noGeorge, C. F. Izici ezithinta ukutholakala ngokuphelele kwe-nifedipine. UBr J Clin Pharmacol 1995; 40: 51-58. Buka okungaqondakali.
  69. ULundahl, J., Conth, C. G., Edgar, B., noJohnsson, G. Ubudlelwano phakathi kwesikhathi sokudla ijusi lamagilebhisi nomphumela wakho kuma-pharmacokinetics nakuma-pharmacodynamics we-felodipine ezifundweni ezinempilo. I-Eur J Clin Pharmacol 1995; 49 (1-2): 61-67. Buka okungaqondakali.
  70. ULundahl, J., Conth, C. G., Edgar, B., noJohnsson, G. Imiphumela yokungenisa ujusi wamagilebhisi - i-pharmacokinetics kanye ne-haemodynamics ye-felodipine efakwa ngomlomo nangomlomo emadodeni anempilo. I-Eur J Clin Pharmacol 1997; 52: 139-145. Buka okungaqondakali.
  71. UHashimoto, K., Shirafuji, T., Sekino, H., Matsuoka, O., Sekino, H., Onnagawa, O., Okamoto, T., Kudo, S., no-Azuma, J. Ukusebenzisana kwamajusi e-citrus i-pranidipine, umphikisi omusha we-1,4-dihydropyridine calcium, ezifundweni ezinempilo. I-Eur J Clin Pharmacol 1998; 54 (9-10): 753-760. Buka okungaqondakali.
  72. UFuhr, U., Maier-Bruggemann, A., Blume, H., Muck, W., Unger, S., Kuhlmann, J., Huschka, C., Zaigler, M., Rietbrock, S., noStaib, Ijusi lamagilebhisi le-AH lenyusa ukutholakala komlomo kwe-nimodipine. I-Int J Clin Pharmacol Ther 1998; 36: 126-132. Buka okungaqondakali.
  73. IGoosen, TC, Cillie, D., Bailey, DG, Yu, C., He, K., Hollenberg, PF, Woster, PM, Cohen, L., Williams, JA, Rheeders, M., noDijkstra, HP Bergamottin umnikelo ekusebenzisaneni kwejusi lamagilebhisi-felodipine nokuma kwabantu. I-Clin Pharmacol Ther 2004; 76: 607-617. Buka okungaqondakali.
  74. U-Edgar, B., Bailey, D., Bergstrand, R., Johnsson, G., no-Such, C. G. Imiphumela emibi yokuphuza ijusi lamagilebhisi ku-pharmacokinetics namandla we-felodipine - nokubaluleka kwayo emtholampilo. I-Eur J Clin Pharmacol 1992; 42: 313-317. Buka okungaqondakali.
  75. UChristensen, H., Asberg, A., Holmboe, A. B., noBerg, K. J. Ukuphathwa kwejusi lezithelo zomvini kukhulisa ukuvezwa kwesistimu kwe-diltiazem kumavolontiya anempilo. I-Eur J Clin Pharmacol 2002; 58: 515-520. Buka okungaqondakali.
  76. UBailey, D. G., Arnold, J. M., Bend, J. R., Tran, L.T, noSpence, J. D. Grapefruit ukusebenzisana kwejusi-felodipine: ukukhiqiza kabusha kanye nokwenza okuthile ngokwakhiwa kwezidakamizwa okunwetshiwe. UBr J Clin Pharmacol 1995; 40: 135-140. Buka okungaqondakali.
  77. UBailey, D. G., Arnold, J. M., Munoz, C., noSpence, J. D. Grapefruit juice - felodipine ukuxhumana: indlela, ukubikezela, nomphumela we-naringin. I-Clin Pharmacol Ther 1993; 53: 637-642. Buka okungaqondakali.
  78. Schwarz, U. I., Seemann, D., Oertel, R., Miehlke, S., Kuhlisch, E., Fromm, M. F., Kim, R. B., Bailey, D. G., noKirch, W.Ukufakwa kwejusi yamagilebhisi kunciphisa kakhulu ukutholakala kwe-talinolol. I-Clin Pharmacol Ther 2005; 77: 291-301. Buka okungaqondakali.
  79. USugimoto, K., Araki, N., Ohmori, M., Harada, K., Cui, Y., Tsuruoka, S., Kawaguchi, A., noFujimura, A. Ukusebenzisana phakathi kukalamanzi wamagilebhisi nezidakamizwa eziluthayo: ukuqhathanisa i-triazolam ne-quazepam. I-Eur J Clin Pharmacol 2006; 62: 209-215. Buka okungaqondakali.
  80. IHugen, PW, Burger, DM, Koopmans, PP, Stuart, JW, Kroon, FP, van Leusen, R., noHekster, YA Saquinavir soft-gel capsules (Fortovase) anika ukuvezwa okuncane kunalokho obekulindelekile, noma ngabe ngemuva kwamafutha aphezulu ibhulakufesi. I-Pharm World Sci 2002; 24: 83-86. Buka okungaqondakali.
  81. UCulm-Merdek, KE, von Moltke, LL, Gan, L., Horan, KA, Reynolds, R., Harmatz, JS, Court MH, noGreenblatt, DJ Umphumela wokuchayeka okuthe xaxa kumjusi wamagilebhisi ku-cytochrome P450 3A umsebenzi kubantu : ukuqhathanisa ne-ritonavir. I-Clin Pharmacol Ther 2006; 79: 243-254. Buka okungaqondakali.
  82. UCuong, B. T., Binh, V. Q., Dai, B., Duy, D. N., Lovell, C. M., Rieckmann, K. H., no-Edstein, M. D. Ngabe ubulili, ukudla noma ujusi wamagilebhisi kuguqula i-pharmacokinetics ye-primaquine ezifundweni ezinempilo? UBr J Clin Pharmacol 2006; 61: 682-689. Buka okungaqondakali.
  83. UCharbit, B., Becquemont, L., Lepere, B., Peytavin, G., noFunck-Brentano, C. Ukusebenzisana kwe-Pharmacokinetic kanye ne-pharmacodynamic phakathi kwejusi lamagilebhisi ne-halofantrine. I-Clin Pharmacol Ther 2002; 72: 514-523. Buka okungaqondakali.
  84. U-Lilja, J. J., Neuvonen, M., no-Neuvonen, P. J. Imiphumela yokusetshenziswa okujwayelekile kwejusi lamagilebhisi ku-pharmacokinetics ye-simvastatin. UBr J Clin Pharmacol 2004; 58: 56-60. Buka okungaqondakali.
  85. Ando, ​​H., Tsuruoka, S., Yanagihara, H., Sugimoto, K., Miyata, M., Yamazoe, Y., Takamura, T., Kaneko, S., noFujimura, A. Imiphumela yejusi lamagilebhisi i-pharmacokinetics ye-pitavastatin ne-atorvastatin. UBr J Clin Pharmacol 2005; 60: 494-497. Buka okungaqondakali.
  86. UClifford, C. P., Adams, D. A., Murray, S., Taylor, G. W., Wilkins, M. R., Boobis, A. R., noDavies, D. S. Imiphumela yenhliziyo ye-terfenadine ngemuva kokuvinjelwa kwemetabolism yayo ngejusi lamagilebhisi. I-Eur J Clin Pharmacol 1997; 52: 311-315. Buka okungaqondakali.
  87. UBenton, R. E., Honig, P.K, Zamani, K., Cantilena, L. R., noWoosley, R. L. Ijusi lamagilebhisi liguqula i-terfenadine pharmacokinetics, okuholela ekwandisweni kokuphindwaphindwa kwe-electrocardiogram. I-Clin Pharmacol Ther 1996; 59: 383-388. Buka okungaqondakali.
  88. Kawakami, M., Suzuki, K., Ishizuka, T., Hidaka, T., Matsuki, Y., noNakamura, H. Umphumela wejusi lamagilebhisi ku-pharmacokinetics ye-itraconazole ezifundweni ezinempilo. I-Int J Clin Pharmacol Ther 1998; 36: 306-308. Buka okungaqondakali.
  89. U-Lee, A. J., Chan, W. K., Harralson, A. F., Buffum, J., noBui, B. C. Imiphumela yejusi lamagilebhisi ku-sertraline metabolism: i-in vitro kanye ne-vivo Study. Umtholampilo Ther 1999; 21: 1890-1899. Buka okungaqondakali.
  90. Min, D. I., Ku, Y. M., Geraets, D. R., no Lee, H. Umphumela wejusi lamagilebhisi ku-pharmacokinetics nakuma-pharmacodynamics we-quinidine kumavolontiya anempilo. UJ Clin Pharmacol 1996; 36: 469-476. Buka okungaqondakali.
  91. Libersa, CC, Brique, SA, Motte, KB, Caron, JF, Guedon-Moreau, LM, Humbert, L., Vincent, A., Devos, P., noLhermitte, MA Ukuvinjelwa okumangazayo kwe-amiodarone metabolism okubangelwa ijusi lamagilebhisi . UBr J Clin Pharmacol 2000; 49: 373-378. Buka okungaqondakali.
  92. UKupferschmidt, H. H., Ha, H. R., Ziegler, W. H., Meier, P. J., noKrahenbuhl, S. Ukusebenzisana phakathi kukalamanzi wamagilebhisi no-midazolam kubantu. I-Clin Pharmacol Ther 1995; 58: 20-28. Buka okungaqondakali.
  93. I-Hukkinen, S. K., Varhe, A., Olkkola, K. T., ne-Neuvonen, P. J. Ukugxilwa kwe-Plasma kwe-triazolam kwandiswa ngokungenisa okuhlanganayo kwejusi lamagilebhisi. I-Clin Pharmacol Ther 1995; 58: 127-131. Buka okungaqondakali.
  94. Andersen, V., Pedersen, N., Larsen, N. E., Sonne, J., noLarsen, S. Intestinal first pass metabolism of midazolam in liver cirrhosis - umphumela wejuzi yamagilebhisi. UBr J Clin Pharmacol 2002; 54: 120-124. Buka okungaqondakali.
  95. USigusch, H., Hippius, M., Henschel, L., Kaufmann, K., noHoffmann, A. Ithonya lejusi lamagilebhisi ku-pharmacokinetics yokwenziwa kancane kwe-nifedipine formulation. I-Pharmazie 1994; 49: 522-524. Buka okungaqondakali.
  96. Hollander, AA, van Rooij, J., Lentjes, GW, Arbouw, F., van Bree, JB, Schoemaker, RC, van Es, LA, van der Woude, FJ, noCohen, AF Umphumela wejusi lamagilebhisi ku-cyclosporine kanye ne-prednisone metabolism ekufakeleni iziguli. I-Clin Pharmacol Ther 1995; 57: 318-324. Buka okungaqondakali.
  97. ULilja JJ, Raaska K, Neuvonen PJ. Imiphumela yejusi lamagilebhisi ku-pharmacokinetics ye-acebutolol. UBr J Clin Pharmacol 2005; 60: 659-63. Buka okungaqondakali.
  98. I-Yin OQ, uGallagher N, uLi A, et al. Umphumela wejusi lamagilebhisi ku-pharmacokinetics ye-nilotinib kubahlanganyeli abaphilile. UJ Clin Pharmacol 2010; 50: 188-94. Buka okungaqondakali.
  99. UBenmebarek M, uDevaud C, uGex-Fabry M, et al. Imiphumela yejusi lamagilebhisi ku-pharmacokinetics yama-enantiomers we-methadone. I-Clin Pharmacol Ther 2004; 76: 55-63. Buka okungaqondakali.
  100. UHori H, Yoshimura R, Ueda N, et al. Ukusebenzisana kwe-grapefruit juice-fluvoxamine - kuyingozi noma cha? UJ Clin Psychopharmacol 2003; 23: 422-4. Buka okungaqondakali.
  101. UYasui N, Kondo T, Furukori H, et al. Imiphumela yokungeniswa okuphindaphindiwe kwejusi lamagilebhisi ku-pharmacokinetics eyodwa ne-multiple-dose pharmacokinetics kanye ne-pharmacodynamics ye-alprazolam. I-Psychopharmacology (Berl) 2000; 150: 185-90. Buka okungaqondakali.
  102. UDemarles D, uGillotin C, Bonaventure-Paci S, et al. I-pharmacokinetics yedosi elilodwa le-amprenavir elawulwa ngejusi lamagilebhisi. Ama-Antimicrob Agents Chemother 2002; 46: 1589-90. Buka okungaqondakali.
  103. Imininingwane yomkhiqizo weCordarone. Abakwa-Wyeth Pharmaceuticals, Inc.IPhiladelphia, PA 19101. Septhemba 2006.
  104. I-Bailey DG, i-Dresser GK, i-Leake BF, uKim RB. INaringin iyi-inhibitor enkulu futhi ekhethiwe yomtholampilo we-organic anion-transporting polypeptide 1A2 (OATP1A2) kujusi we-grapefruit. I-Clin Pharmacol Ther 2007; 81: 495-502. Buka okungaqondakali.
  105. UBailey DG. Ijusi yezithelo ukuvimba ukuthuthwa kokuthathwa: uhlobo olusha lokuxhumana kwezidakamizwa. UBr J Clin Pharmacol 2010; 70: 645-55. Buka okungaqondakali.
  106. IGreenblatt DJ. Ukuhlaziywa kokusebenzisana kwezidakamizwa okubandakanya iziphuzo zezithelo kanye ne-organic anion-transporting polypeptides. UJ Clin Pharmacol 2009; 49: 1403-7. Buka okungaqondakali.
  107. I-Dresser GK, uKim RB, uBaley DG. Umphumela wevolumu yesithelo samagilebhisi ekwehliseni i-fexofenadine bioavailability: indima engaba khona ye-organic anion ethutha ama-polypeptides. I-Clin Pharmacol Ther 2005; 77: 170-7. Buka okungaqondakali.
  108. Ukuhlangana okungenzeka kwezidakamizwa no-grapefruit. Incwadi ka-Pharmacist's Letter / Prescriber's 2007; 23: 230204.
  109. UFarkas D, u-Oleson LE, uZhao Y, et al. Ijusi lepomegranate alonakalisi ukususwa kwe-midazolam yomlomo noma efakwa ngaphakathi, iphenyo yomsebenzi we-cytochrome P450-3A: ukuqhathanisa nejusi lamagilebhisi. UJ Clin Pharmacol 2007; 47: 286-94. Buka okungaqondakali.
  110. UMonroe KR, uMurphy SP, uKolonel LN, uPike MC. Ukucwaninga okulindelekile kokudla kwe-grapefruit kanye nengozi yomdlavuza webele kwabesifazane be-postmenopausal: Isifundo seMutliethnic Cohort. Br J Umdlavuza 2007; 97: 440-5. Buka okungaqondakali.
  111. UZitron E, Scholz E, Owen RW, et al. Ukwandiswa kwe-QTc ngejusi lamagilebhisi kanye nesisekelo sayo esingaba semithi: Ukuvinjelwa kwesiteshi se-HERG ngama-flavonoids. Ukusakazwa 2005; 835: 835-8. Buka okungaqondakali.
  112. U-Unger M, uFrank A. Ukuzimisela ngasikhathi sinye kwamandla okuvimbela ukukhishwa kwamakhambi ekusebenzeni kwama-enzyme ayisithupha amakhulu e-cytochrome P450 asebenzisa i-liquid chromatography / mass spectrometry kanye ne-automated online extraction. I-Massid Commun Mass Spectrom 2004; 18: 2273-81. Buka okungaqondakali.
  113. UFukazawa I, Uchida N, Uchida E, Yasuhara H. Imiphumela yejusi lamagilebhisi kuma-pharmacokinetics we-atorvastatin ne-pravastatin ngesiJapane. UBr J Clin Pharmacol 2003; 57: 448-55. Buka okungaqondakali.
  114. ISullivan DM, iFord MA, iBoyden TW. Ijusi lamagilebhisi nempendulo ye-warfarin. NginguJ J Health-Syst Pharm 1998; 55: 1581-3. Buka okungaqondakali.
  115. UGaudineau C, Beckerman R, Welbourn S, Auclair K. Ukuvinjelwa kwama-enzyme womuntu we-P450 ngabantu abaningi bezinto ezikhishwe eGinkgo biloba. I-Biochem Biophys Res Comm 2004; 318: 1072-8. Buka okungaqondakali.
  116. I-Bailey DG, i-Dresser GK, iBend JR. I-Bergamottin, ijusi likalamula, newayini elibomvu njengama-inhibitor womsebenzi we-cytochrome P450 3A4: ukuqhathanisa nejusi lamagilebhisi. I-Clin Pharmacol Ther 2003; 73: 529-37. Buka okungaqondakali.
  117. Ilungu lePhalamende likaDi Marco, u-Edwards DJ, uWainer IW, iLungu lePhalamende laseDucharme. Umphumela wejusi lamagilebhisi kanye nejusi le-seville orange ku-pharmacokinetics ye-dextromethorphan: indima ye-gut CYP3A ne-P-glycoprotein. Impilo Sci 2002; 71: 1149-60. Buka okungaqondakali.
  118. IParker RB, Yates CR, Soberman JE, Laizure SC. Imiphumela yejusi lamagilebhisi ku-P-glycoprotein wamathumbu: ukuhlola kusetshenziswa i-digoxin ebantwini. I-Pharmacotherapy 2003; 23: 979-87. Buka okungaqondakali.
  119. UShelton MJ, Wynn HE, Hewitt RG, DiFrancesco R. Imiphumela yejusi lamagilebhisi ekuvezweni kwe-pharmacokinetic ku-indinavir ezifundweni ezine-HIV. UJ Clin Pharmacol 2001; 41: 435-42. Buka okungaqondakali.
  120. I-Dresser GK, i-Bailey DG, i-Leake BF, et al. Iziphuzo zezithelo zivimbela i-organic anion ethutha ukutholwa kwezidakamizwa ze-polypeptide-mediated ukunciphisa ukutholakala ngomlomo kwe-fexofenadine. I-Clin Pharmacol Ther 2002; 71: 11-20. Buka okungaqondakali.
  121. I-Becquemont L, i-Verstuyft C, i-Curb R, et al. Umphumela wejusi lamagilebhisi ku-digoxin pharmacokinetics kubantu. I-Clin Pharmacol Ther 2001; 70: 311-6. Buka okungaqondakali.
  122. I-Bailey DG, i-Dresser GK, iBend JR. I-Bergamottin, ijusi likalamula, newayini elibomvu njengama-inhibitor womsebenzi we-cytochrome P450 3A4: ukuqhathanisa nejusi lamagilebhisi. I-Clin Pharmacol Ther 2003; 73: 529-37. Buka okungaqondakali.
  123. UVeronese ML, uGillen LP, uBurke JP, et al. Ukuvinjelwa okuxhomeke ekubonisweni kwe-CYP3A4 yamathumbu kanye ne-hepatic ku-vivo ngejusi lamagilebhisi. UJ Clin Pharmacol 2003; 43: 831-9. . Buka okungaqondakali.
  124. URogers JD, uZhao J, uLiu L, et al. Ijusi lamagilebhisi linemiphumela emincane ekugxileni kwe-plasma kwe-lovastatin-etholwe yi-3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. IClin Pharmacol Ther 1999; 66: 358-66. Buka okungaqondakali.
  125. USchmiedlin-Ren P, u-Edwards DJ, uFitzsimmons ME, et al. Izindlela zokutholakala komlomo okuthuthukisiwe kwama-substrates e-CYP3A4 ngabakhiqizi bamagilebhisi. Ukwehla kokuhlushwa kwe-enterocyte CYP3A4 kanye nokusebenza okungasuselwa kumishini ngama-furanocoumarins. Izidakamizwa zeMetab Dispos 1997; 25: 1228-33. Buka okungaqondakali.
  126. U-Edwards DJ, uFitzsimmons ME, uSchuetz EG, et al. 6 ', 7'-Dihydroxybergamottin kujusi wamagilebhisi nojusi we-Seville orange: imiphumela ekubunjweni kwe-cyclosporine, i-enterocyte CYP3A4, ne-P-glycoprotein. I-Clin Pharmacol Ther 1999; 65: 237-44. Buka okungaqondakali.
  127. UPenzak SR, Acosta EP, Turner M, et al. Umphumela wejusi le-orange laseSeville kanye nejusi lamagilebhisi ku-indinavir pharmacokinetics. UJ Clin Pharmacol 2002; 42: 1165-70. Buka okungaqondakali.
  128. IGupta MC, uGarg SK, uBadyal D, et al. Umphumela wejusi lamagilebhisi ku-pharmacokinetics ye-theophylline kumavolontiya wesilisa anempilo. Izindlela Zokuthola I-Exp Clin Pharmacol 1999; 21: 679-82. Buka okungaqondakali.
  129. UGreenblatt DJ, von Moltke LL, uHarmatz JS. Isikhathi sokululama komsebenzi we-cytochrome P450 3A ngemuva kokulinganisa okukodwa kwejusi lamagilebhisi. I-Clin Pharmacol Ther 2003; 74: 121-29. Buka okungaqondakali.
  130. UHermans K, uStockman D, uVan den Branden F. Amagilebhisi kanye ne-tonic: inhlanganisela ebulalayo esigulini esine-QT syndrome ende. NginguJ Med 2003; 114: 511-512.
  131. UReif S, uNicolson M, uBisset D, et al. Umphumela wokudla kwejusi yamagilebhisi ku-etoposide bioavailability. I-Eur J Clin Pharmacol 2002; 58: 491-4 .. Buka okungaqondakali.
  132. Kanazawa S, Ohkubo T, Sugawara K. Imiphumela yejusi lamagilebhisi ku-pharmacokinetics ye-erythromycin. I-Eur J Clin Pharmacol 2001; 56: 799-803. Buka okungaqondakali.
  133. UFuhr U, uMuller-Peltzer H, uKern R, et al. Imiphumela yejusi lamagilebhisi nokubhema ezingxenyeni ze-verapamil esimweni esizinzile. I-Eur J Clin Pharmacol 2002; 58: 45-53. Buka okungaqondakali.
  134. U-Ebert U, Oertel R, Kirch W. Umthelela wejusi lamagilebhisi ku-scopolamine pharmacokinetics kanye ne-pharmacodynamics ezifundweni zesilisa nabesifazane ezinempilo. I-Int J Clin Pharmacol Ther 2000; 38: 523-31. Buka okungaqondakali.
  135. UJetter A, uKinzig-Schippers M, uWalchner-Bonjean M, et al. Imiphumela yejusi lamagilebhisi ku-pharmacokinetics ye-sildenafil. I-Clin Pharmacol Ther 2002; 71: 21-9. Buka okungaqondakali.
  136. UCastro N, uJung H, uMedina R, et al. Ukusebenzisana phakathi kwejusi lamagilebhisi ne-praziquantel kubantu. Ama-Antimicrob Agents Chemother 2002; 46: 1614-6. Buka okungaqondakali.
  137. Lilja JJ, Kivisto KT, Neuvonen PJ. Isikhathi somthelela wejusi lamagilebhisi ku-pharmacokinetics ye-CYP3A4 substrate simvastatin. IClin Pharmacol Ther 2000; 68: 384-90. Buka okungaqondakali.
  138. I-Bailey DG, i-Dresser GK. Ukusebenzisana kwejusi le-lovastatin yamagilebhisi. I-Clin Pharmacol Ther 2000; 67: 690. Buka okungaqondakali.
  139. Uno T, Ohkubo T, uSugawara K, et al. Imiphumela yejusi lezithelo zomvini ekubhekeni kwe-nicardipine kubantu: ubufakazi bokuqedwa kwendlela yokusebenza endaweni yamathumbu. I-Eur J Clin Pharmacol 2000; 56: 643-9. Buka okungaqondakali.
  140. I-Ho PC, i-Ghose K, i-Saville D, i-Wanwimolruk S. Umphumela wejusi lamagilebhisi kuma-pharmacokinetics nakuma-pharmacodynamics we-verapamil enantiomers kumavolontiya anempilo. I-Eur J Clin Pharmacol 2000; 56: 693-8. Buka okungaqondakali.
  141. UChan WK, Nguyen LT, uMiller VP, uHarris RZ. Ukungasebenzi okususelwa kwimishini kwe-cytochrome yomuntu i-P450 3A4 ngejusi lamagilebhisi kanye newayini elibomvu. ILife Sci 1998; 62: PL135-42. Buka okungaqondakali.
  142. U-Erlund I, uMeririnne E, u-Alfthan G, u-Aro A. Plasma kinetics kanye nokukhishwa komchamo kwe-flavanones naringenin ne-hesperetin ebantwini ngemuva kokungeniswa kukalamusi we-orange kanye nejusi lamagilebhisi. J Umsoco 2001; 131: 235-41. Buka okungaqondakali.
  143. Lilja JJ, Kivisto KT, Backman JT, Neuvonen PJ. Umphumela womthamo wejusi lamagilebhisi ku-grapefruit juice-triazolam ukuxhumana: ukusetshenziswa okuphindaphindwayo kwandisa i-triazolam half-life. I-Eur J Clin Pharmacol 2000; 56: 411-5. Buka okungaqondakali.
  144. I-Bailey DG, i-Dresser GK, uMunoz C, et al. Ukwehliswa kwe-fexofenadine bioavailability ngamajusi wezithelo. IClin Pharmacol Ther 2001; 69: P21.
  145. I-Dresser GK, i-Bailey DG, iCarruthers SG. Ukusebenzisana kwe-juice-felodipine kubantu asebekhulile. I-Clin Pharmacol Ther 2000; 68: 28-34. Buka okungaqondakali.
  146. ITroisi RJ, iWillett WC, i-Weiss ST, et al. Ucwaningo olulindelekile lokudla nesifo somoya esidala sabantu abadala. Ngingu-J J Respir Crit Care Med 1995; 151: 1401-8. Buka okungaqondakali.
  147. I-Butland BK, i-Fehily AM, i-Elwood PC. Ukudla, ukusebenza kwamaphaphu, kanye nomsebenzi wamaphaphu kwehla kuqoqo lamadoda asebekhulile angama-2512. Isikhulu 2000; 55: 102-8. Buka okungaqondakali.
  148. USchwartz J, Weiss ST. Ubudlelwano phakathi kokudla kwe-vitamin C kanye nokusebenza kwamaphaphu ku-First National Health and Nutrition Examination Survey (NHANES I). Ngingu-J J Nutriti 1994; 59: 110-4. Buka okungaqondakali.
  149. ICarey IM, iStrachan DP, iCook DG. Imiphumela yezinguquko ekusetshenzisweni kwezithelo ezintsha ekusebenzeni komoya kubantu abadala baseBrithani abanempilo. Ngingu-J J Respir Crit Care Med 1998; 158: 728-33. Buka okungaqondakali.
  150. Dweba GE. I-asthma, ama-oxidants angenisiwe, nama-antioxidants wokudla. Ngingu-J J Nutriti 1995; 61: 625S-30S. Buka okungaqondakali.
  151. UForastiere F, uPistelli R, uSestini P, et al. Ukusetshenziswa kwezithelo ezintsha ezicebile ku-vitamin C nezimpawu zokuthimulisa ezinganeni. Isikhulu 2000; 55: 283-8. Buka okungaqondakali.
  152. UVon Woedtke T, uSchluter B, uPflegel P, et al. Izici zokwenza kahle kwama-antimicrobial we-grapefruit imbewu ekhishwe kanye nokuhlobana kwayo nezinto zokubulala eziqukethwe. I-Pharmazie 1999; 54: 452-6. Buka okungaqondakali.
  153. U-Ionescu G, uKiehl F, uWichmann-Kunz F, et al. Ukukhishwa kwembewu ye-citrus yomlomo ku-atopic eczema: ku-in vitro nasezifundweni ze-vivo ku-microflora yamathumbu. UJ Orthomolec Med 1990; 5: 155-7.
  154. URanzani MR, uFonseca H. Ukuhlolwa kwe-Mycological kwamakinati aphethwe amakhemikhali aphethwe ngamakhemikhali. I-Addit Contam Yezokudla 1995; 12: 343-6. Buka okungaqondakali.
  155. I-Calori-Domingues MA, i-Fonseca H. Ukuhlolwa kwelabhoratri kokulawulwa kwamakhemikhali kokukhiqizwa kwe-aflatoxin kumantongomane angashiswanga (Arachis hypogaea L.). I-Addit Contam Yezokudla 1995; 12: 347-50. Buka okungaqondakali.
  156. USakamoto S, Sato K, Maitani T, Yamada T. [Ukuhlaziywa kwezingxenye kokudla okusemvelweni "okukhishwe imbewu yamagilebhisi" yi-HPLC ne-LC / MS]. U-Eisei Shikenjo Hokoku 1996;: 38-42. Buka okungaqondakali.
  157. Xiong H, Li Y, Slavik MF, Walker JT. Ukufafaza isikhumba senkukhu ngamakhemikhali akhethiwe ukunciphisa iSalmonella typhimurium enamathiselwe. J Ukudla Prot 1998; 61: 272-5. Buka okungaqondakali.
  158. Yena K, Iyer KR, Hayes RN, et al. Ukungasebenzi kwe-cytochrome P450 3A4 yi-bergamottin, ingxenye yejusi lamagilebhisi. IChem Res Toxicol 1998; 11: 252-9. Buka okungaqondakali.
  159. I-Coreg monograph. Ku: Gillis MC, u-Ed. Ukuhlanganiswa Kwezemithi Nobuchwepheshe (CPS). Umhla ka-34. I-Ottawa, Ontario, CAN: Osokhemisi baseCanada u-Assn, 1999: 395.
  160. Isigqoki GK, Spence JD, Bailey DG. Imiphumela ye-Pharmacokinetic-pharmacodynamic nokubaluleka komtholampilo kwe-cytochrome P450 3A4 inhibition. Umtholampilo Pharmacokinet 2000; 38: 41-57. Buka okungaqondakali.
  161. UTakanaga H, Ohnishi A, Matsuo H, et al. Ukuhlaziywa kwe-Pharmacokinetic kokusebenzisana kwejusi le-felodipine-grapefruit kususelwa kumodeli yokuvimbela i-enzyme engalungiseki. UBr J Clin Pharmacol 2000; 49: 49-58. Buka okungaqondakali.
  162. UTakanaga H, Ohnishi A, Murakami H, et al. Ubudlelwano phakathi kwesikhathi ngemuva kokudla ijusi yamagilebhisi nomphumela we-pharmacokinetics kanye ne-pharmacodynamics ye-nisoldipine ezifundweni ezinempilo. I-Clin Pharmacol Ther 2000: 67: 201-14. Buka okungaqondakali.
  163. UDamkier P, uHansen LL, uBrosen K. Umphumela we-diclofenac, i-disulfiram, i-itraconazole, ujusi wamagilebhisi kanye ne-erythromycin ku-pharmacokinetics ye-quinidine. UBr J Clin Pharmacol 1999; 48: 829-38. Buka okungaqondakali.
  164. van Agtmael MA, Gupta V, van der Graaf CA, van Boxtel CJ. Umphumela wejusi lamagilebhisi ekwehleni okuncike esikhathini samazinga e-artemether plasma ezifundweni ezinempilo. IClin Pharmacol Ther 1999; 66: 408-14. Buka okungaqondakali.
  165. van Agtmael MA, Gupta V, van der Wosten TH, et al. Ijusi lamagilebhisi lenyusa ukutholakala kwe-artemether. I-Eur J Clin Pharmacol 1999; 55: 405-10. Buka okungaqondakali.
  166. U-Oesterheld J, uKallepalli BR. Ijusi lamagilebhisi kanye ne-clomipramine: ukuguqula isilinganiso se-metabolitic. UJ Clin Psychopharmacol 1997; 17: 62-3.
  167. Ikhodi ye-elekthronikhi yemithethonqubo kahulumeni. Isihloko 21. Ingxenye 182 - Izinto Ngokuvamile Zaziwa Njengokuphepha. Kutholakala ku: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
  168. Evans AM. Ithonya lezinto zokudla emzimbeni we-gastrointestinal metabolism kanye nokuthuthwa kwezidakamizwa. I-Ther Drug Monit 2000; 22: 131-6. Buka okungaqondakali.
  169. Ukusebenzisana Kwezidakamizwa zikaFuhr U. nejusi lamagilebhisi. Izidakamizwa Saf 1998; 18: 251-72. Buka okungaqondakali.
  170. UCurhan GC, uWillett WC, uSomizer FE, uStamfer MJ. Ukusetshenziswa kwesiphuzo kanye nobungozi bamatshe ezinso kwabesifazane. U-Ann Intern Med 1998; 128: 534-40. Buka okungaqondakali.
  171. Ameer B, Weintraub RA. Ukusebenzisana kwezidakamizwa nejusi lamagilebhisi. Umtholampilo Pharmacokinet 1997; 33: 103-21. Buka okungaqondakali.
  172. Lilja JJ, Kivisto KT, Neuvonen PJ. Ukusebenzisana kwe-juice-simvastatin yamagilebhisi: umphumela ekugxileni kwe-serum ye-simvastatin, i-simvastatin acid, ne-HMG-CoA reductase inhibitors. I-Clin Pharmacol Ther 1998; 64: 477-83. Buka okungaqondakali.
  173. UKupferschmidt HH, uFattinger KE, Ha HR, et al. Ijusi lamagilebhisi lithuthukisa ukutholakala kokutholakala kwe-HIV protease inhibitor saquinavir kumuntu. UBr J Clin Pharmacol 1998; 45: 355-9. Buka okungaqondakali.
  174. ULilja JJ, uKivisto KT, uBackman JT, et al. Ijusi lamagilebhisi lenyusa kakhulu ukugxila kwe-plasma kwe-buspirone. I-Clin Pharmacol Ther 1998; 64: 655-60. Buka okungaqondakali.
  175. UFukuda K, Ohta T, Oshima Y, et al. I-CYP3A4 inhibitors ethile kujusi wamagilebhisi: ama-furocoumarin dimers njengezinto zokusebenzisana kwezidakamizwa. I-Pharmacogenetics 1997; 7: 391-6. Buka okungaqondakali.
  176. UZhang YD, uLorenzo B, Reidenberg MM. Ukuvinjelwa kwe-11 beta hydroxysteroid dehydrogenase etholwe ku-Guinea pig kid by furosemide, naringenin namanye ama-compounds. J Steroid Biochem Mol Biol 1994; 49: 81-5. Buka okungaqondakali.
  177. U-Lee YS, uLorenzo BJ, uKoufis T, et al. Ijusi lamagilebhisi nama-flavonoid alo avimbela i-beta-hydroxysteroid dehydrogenase eyi-11. I-Clin Pharmacol Ther 1996; 59: 62-71. Buka okungaqondakali.
  178. UZaidenstein R, uDishi V, uGips M, et al. Umphumela wejusi lamagilebhisi ku-pharmacokinetics ye-verapamil elawulwa ngomlomo. I-Eur J Clin Pharmacol 1998; 54: 337-40. Buka okungaqondakali.
  179. Ukusebenzisana kwezithelo zomvini. Kutholakala ku: www.powernetdesign.com/grapefruit (Kufinyelelwe ngomhla ka-26 Septhemba 1999).
  180. I-Ozdemir M, i-Aktan Y, i-Boydag BS. Ukusebenzisana phakathi kwejusi lamagilebhisi kanye ne-diazepam kubantu. I-Eur J Drug Metab Pharmacokinet 1998; 23: 55-9. Buka okungaqondakali.
  181. Lilja JJ, Kivisto KT, Neuvonen PJ. Ijusi lamagilebhisi lenyusa ukugxila kwe-serum kwe-atorvastatin futhi alinawo umthelela ku-pravastatin. IClin Pharmacol Ther 1999; 66: 118-27. Buka okungaqondakali.
  182. Gross AS, Goh YD, Addison RS, et al. Ithonya lejusi lamagilebhisi ku-cisapride pharmacokinetics. I-Clin Pharmacol Ther 1999; 65: 395-401. Buka okungaqondakali.
  183. UVaris T, uKivisto KT, uNeuvonen PJ. Ijusi lamagilebhisi lingakhuphula ukugcwala kwe-plasma kwe-methylprednisolone. I-Eur J Clin Pharmacol 2000; 56: 489-93. Buka okungaqondakali.
  184. UCerda JJ, uRobbins FL, uBurgin CW, et al. Imiphumela ye-grapefruit pectin ezigulini ezisengozini yesifo senhliziyo ngaphandle kokushintsha ukudla noma indlela yokuphila. Umtholampilo Cardiol 1988; 11: 589-94. Buka okungaqondakali.
  185. I-Dresser GK, i-Bailey DG, iCarruthers SG. Ukusebenzisana kwe-grapefruit juice-felodipine kubantu abadala abanempilo. I-Clin Pharmacol Ther 1998; 65: (i-abstract PIII-63).
  186. UZaidenstein R, Avni B, Dishi V, et al. Umphumela wejusi lamagilebhisi ku-pharmacokinetics ye-losartan kumavolontiya anempilo. I-Clin Pharmacol Ther 1998; 65: (i-abstract PI-60).
  187. USoldner A, amaKrestu U, uSusanto M, et al. Ijusi lamagilebhisi lenza ukuhanjiswa kwezidakamizwa okulawulwa yi-P-glycoprotein. I-Pharm Res 1999; 16: 478-85. Buka okungaqondakali.
  188. I-Bailey DG, i-Dresser GK, i-Kreeft JH, et al. Ukusebenzisana kwe-juice-felodipine ye-Grapefruit: Umphumela wamasegmenti kanye nesithelo esivela kwisithelo esingasetshenziswanga. I-Clin Pharmacol Ther 2000; 67: 107 (i-abstract PI-71).
  189. UVeronese M, uBurke J, uDorval E, et al. Ijusi lamagilebhisi (i-GFJ) livimbela umthamo we-hepatic namathumbu ngokuya ngomthamo. IClin Pharmacol Ther 2000; 67: 151 (i-abstract PIII-37).
  190. I-Offman EM, i-Freeman DJ, i-Dresser GK, et al. Ukusebenzisana kweCisapride nejusi yamagilebhisi newayini elibomvu. I-Clin Pharmacol Ther 2000; 67: 110 (i-abstract PI-83).
  191. URobbins RC, uMartin FG, uRoe JM. Ukungeniswa kwamagilebhisi kwehlisa ama-hematocrits aphakeme ezifundweni zabantu. I-Int J Vitam Nutr Res 1988; 58: 414-7. Buka okungaqondakali.
  192. URau SE, uBend JR, u-Arnold MO, et al. Ukusebenzisana kwe-grapefruit juice-terfenadine single-dose: ubukhulu, indlela yokusebenza, nokubaluleka. I-Clin Pharmacol Ther 1997 61: 401-9. Buka okungaqondakali.
  193. UBailey DG, u-Arnold JM, uStrong HA, et al. Umphumela wejusi lamagilebhisi kanye ne-naringin ku-nisoldipine pharmacokinetics. I-Clin Pharmacol Ther 1993; 54: 589-94. Buka okungaqondakali.
  194. I-Bailey DG, iSpence JD, uMunoz C, u-Arnold JM. Ukusebenzisana kwamajusi e-citrus ne-felodipine ne-nifedipine. ILancet 1991; 337: 268-9. Buka okungaqondakali.
  195. UKantola T, Kivisto KT, Neuvonen PJ, et al. Ijusi lamagilebhisi lenyusa kakhulu ukugxila kwe-serum ye-lovastatin ne-lovastatin acid. I-Clin Pharmacol Ther 1998 63: 397-402. Buka okungaqondakali.
  196. USchubert W, uCullberg G, u-Edgar B, uHedner T. Ukuvinjelwa kwe-17 beta-estradiol metabolism ngejusi lamagilebhisi kwabesifazane aba-ovariectomized. UMatritas 1994; 20: 155-63. Buka okungaqondakali.
  197. U-Weber A, uJager R, uBorner A, et al. Ingabe ijusi lamagilebhisi lingathonya ukutholakala kwe-ethinylestradiol? Ukuvimbela inzalo 1996; 53: 41-7. Buka okungaqondakali.
  198. IGarg SK, Kumar N, Bhargava VK, Prabhakar SK. Umphumela wejusi lamagilebhisi ku-carbamazepine bioavailability ezigulini ezinesithuthwane. I-Clin Pharmacol Ther 1998; 64: 286-8. Buka okungaqondakali.
  199. UJosefsson M, uZackrisson AL, Ahlner J. Umphumela wejusi lamagilebhisi ku-pharmacokinetics ye-amlodipine kumavolontiya anempilo. I-Eur J Clin Pharmacol 1996; 51: 189-93. Buka okungaqondakali.
  200. U-Ioannides-Demos LL, uChristophidis N, et al. Ukulinganisa imiphumela yokuhlangana komtholampilo phakathi kwejusi lamagilebhisi kanye ne-cyclosporine kanye nokugxila kwe-metabolite ezigulini ezinezifo ezizimele. UJ Rheumatol 1997; 24: 49-54. Buka okungaqondakali.
  201. I-Agri Res Svc: Imininingwane yolwazi kaDkt Duke ne-ethnobotanical. www.ars-grin.gov/duke (Kufinyelelwe ngomhla ka-3 Novemba 1999).
  202. UPenzak SR, Gubbins PO, Gurley BJ, et al. Ijusi lamagilebhisi lehlisa ukutholakala okuhlelekile kwamaphilisi we-itraconazole kumavolontiya anempilo. I-Ther Drug Monit 1999; 21: 304-9. Buka okungaqondakali.
  203. Ukuphikiswa kukaBrinker F. Herb nokusebenzisana kwezidakamizwa. Okwesibili. USandy, NOMA: I-Eclectic Medical Publications, 1998.
Kugcine ukubuyekezwa - 03/24/2020

Imibhalo Ethandekayo

Ukuqubuka kwesikhumba / ukuqhuma
Umuthi

Ukuqubuka kwesikhumba / ukuqhuma

Ukuqhakaza i ikhumba noma ukufutha kungukubomvu okungazelelwe kobu o, intamo, noma i ifuba e ingenhla ngenxa yokwanda kokugeleza kwegazi.Ukuphalaza kuyimpendulo ejwayelekile yomzimba engahle yenzeke l...
I-Ziprasidone
Umuthi

I-Ziprasidone

Ucwaningo lukhombi ile ukuthi abantu abadala a ebekhulile abanenkinga yokuwohloka komqondo (ukuphazami eka kobuchopho okuthinta ikhono lokukhumbula, ukucabanga kahle, ukuxhumana, nokwenza imi ebenzi y...